<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS207146</article-id><article-id pub-id-type="doi">10.1101/2025.07.09.663707</article-id><article-id pub-id-type="archive">PPR1047517</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A complex of MAST1 and 14-3-3η regulates Tau phosphorylation in the developing cortex</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Antonioli</surname><given-names>Sumire</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Heisterkamp</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Weiqiang</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Anrather</surname><given-names>Dorothea</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Hartl</surname><given-names>Markus</given-names></name><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Martinez-Reza</surname><given-names>Maria-Fernanda</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Tripathy</surname><given-names>Ratna</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Schutzbier</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Mechtler</surname><given-names>Karl</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Keays</surname><given-names>David A.</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Leonard</surname><given-names>Thomas A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cz70a34</institution-id><institution>Max Perutz Labs</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05n3x4p02</institution-id><institution>Medical University of Vienna</institution></institution-wrap>, <addr-line>Dr. Bohr-Gasse 9</addr-line>, <postal-code>1030</postal-code>, <city>Vienna</city>, <country country="AT">Austria</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04khwmr87</institution-id><institution>Vienna BioCenter</institution></institution-wrap> PhD Program, a Doctoral School of the <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03prydq77</institution-id><institution>University of Vienna</institution></institution-wrap> and the <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05n3x4p02</institution-id><institution>Medical University of Vienna</institution></institution-wrap>, <postal-code>A-1030</postal-code><city>Vienna</city>, <country country="AT">Austria</country></aff><aff id="A3"><label>3</label>Division of Neurobiology, Department of Biology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05591te55</institution-id><institution>Ludwig-Maximilians-University Munich</institution></institution-wrap>, <addr-line>Grosshaderner Str. 2</addr-line>, <postal-code>82152</postal-code> Planegg-Martinsried, <country country="DE">Germany</country></aff><aff id="A4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cz70a34</institution-id><institution>Max Perutz Labs</institution></institution-wrap>, Mass Spectrometry Facility, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04khwmr87</institution-id><institution>Vienna Biocenter</institution></institution-wrap><addr-line>Campus (VBC)</addr-line>, <addr-line>Dr. Bohr-Gasse 9</addr-line>, <postal-code>1030</postal-code>, <city>Vienna</city>, <country country="AT">Austria</country></aff><aff id="A5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03prydq77</institution-id><institution>University of Vienna</institution></institution-wrap>, Center for Molecular Biology, Department of Biochemistry and Cell Biology, <addr-line>Dr. Bohr-Gasse 9</addr-line>, <postal-code>1030</postal-code>, <city>Vienna</city>, <country country="AT">Austria</country></aff><aff id="A6"><label>6</label>Faculty of Medicine, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05591te55</institution-id><institution>Ludwig-Maximilians-University Munich</institution></institution-wrap>, <addr-line>Grosshaderner Str. 9</addr-line>, <postal-code>82152</postal-code> Planegg-Martinsried, <country country="DE">Germany</country></aff><aff id="A7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02c5jsm26</institution-id><institution>Institute of Molecular Pathology (IMP)</institution></institution-wrap>, <addr-line>Dr-Bohr Gasse 7</addr-line>, <city>Vienna</city><postal-code>1030</postal-code>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04khwmr87</institution-id><institution>Vienna Biocentre (VBC)</institution></institution-wrap>, <country country="AT">Austria</country></aff><author-notes><corresp id="CR1">
<label>*</label>Correspondence: <email>thomas.leonard@meduniwien.ac.at</email>
</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>14</day><month>07</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>11</day><month>07</month><year>2025</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><title>Summary</title><p id="P1">The MAST family of serine/threonine kinases has been implicated in a spectrum of human neurodevelopmental disorders. However, little is known about their biological function or regulation. Seeking to fill these gaps in our knowledge, we have identified upstream and downstream partners of MAST1. 14-3-3η, a neuronal 14-3-3 paralog, specifically interacts with MAST1 at two regulatory serines, S90 and S161. PAK, a neuronal regulator of the actin cytoskeleton, phosphorylates MAST1 to regulate its interaction with 14-3-3η. Exploiting mouse models of human Mega Corpus Callosum Syndrome (MCC) and whole brain phosphoproteomics, we identify the microtubule-associated protein Tau as a substrate of MAST1. We show that pathogenic MAST1 mutations perturb protein function either through misfolding or attenuation of kinase activity. Our data is consistent with a model in which the MAST kinases couple PAK, a neuronal regulator of the actin cytoskeleton, to microtubule remodeling during the differentiation and specification of cortical neurons.</p></abstract><kwd-group><kwd>Serine/threonine kinase</kwd><kwd>phosphorylation</kwd><kwd>microtubules</kwd><kwd>corpus callosum</kwd><kwd>neurodevelopment</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">The differentiation of cortical neurons is an essential and tightly regulated process, dysregulation of which is associated with a variety of neurodevelopmental disorders (NDDs). A rare NDD called Mega-Corpus-Callosum Syndrome with Cerebellar Hypoplasia and Cortical Malformations (MCC-CH-CM) is characterized by enlargement of the corpus callosum, epilepsy, and severe cognitive and motor impairment <sup><xref ref-type="bibr" rid="R1">1</xref></sup>. Whole exome sequencing of a cohort of seven patients revealed that six harbored <italic>de novo</italic> mutations in a gene called Microtubule Associated Serine/Threonine Kinase 1 (MAST1). A mouse model that recapitulates a heterozygous trinucleotide deletion (L278del) identified in an MCC-CH-CM patient mirrors multiple aspects of the disease, including the enlarged corpus callosum. The identification of additional MCC patients bearing mutations in MAST1, as well as <italic>de novo</italic> mutations in MAST1, MAST3, and MAST4 associated with epilepsy, autism, cerebral palsy, and intellectual disability <sup><xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R9">9</xref></sup> has provided further evidence for the involvement of the MAST kinases in neurodevelopment. Despite their association with human NDDs, very little is known about the biological function, structure, or regulation of any MAST kinase.</p><p id="P3">The MAST kinases are large, ~200 kDa proteins that first arose ~600 million years ago in Cnidaria and Ctenophora, the first organisms with a primitive nervous system <sup><xref ref-type="bibr" rid="R10">10</xref></sup>. They contain three domains; an N-terminal domain of unknown function (DUF) which harbors a four-helix bundle (4HB), a catalytic Ser/Thr kinase domain, and a C-terminal PDZ domain. The kinase domain belongs to the AGC family of protein kinases, characterized by the presence of a regulatory C-terminal tail <sup><xref ref-type="bibr" rid="R11">11</xref></sup>. Although many eukaryotic protein kinases are regulated by activation loop phosphorylation <sup><xref ref-type="bibr" rid="R12">12</xref></sup>, the MAST kinases possess a glutamine in place of the canonical serine or threonine.</p><p id="P4">MAST1 is expressed in post mitotic cortical neurons throughout neurodevelopment <sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R14">14</xref></sup>, associating with the microtubule cytoskeleton via unknown microtubule associated proteins (MAPs) <sup><xref ref-type="bibr" rid="R1">1</xref></sup>. It has been reported that the PDZ domain of MAST1 interacts with the adaptor protein β2-syntrophin, bridging it to the dystrophin/utrophin network at postsynaptic densities <sup><xref ref-type="bibr" rid="R13">13</xref></sup>. Little is known about MAST substrates. MAST1/2/3 and KIN-4 (the sole homolog of MAST kinases in <italic>C. elegans</italic>) reportedly phosphorylate the C-terminus of PTEN in a PDZ domain-dependent manner, however, this interaction has not been confirmed <italic>in vivo</italic> <sup><xref ref-type="bibr" rid="R15">15</xref>–<xref ref-type="bibr" rid="R17">17</xref></sup>. In addition, Mitogen-Activated Protein Kinase Kinase (MEK) <sup><xref ref-type="bibr" rid="R18">18</xref></sup> and cAMP-regulated phosphoprotein of 16 kDa (ARPP-16) <sup><xref ref-type="bibr" rid="R19">19</xref></sup> are also reported substrates. However, these findings are largely based on immunoprecipitated proteins and lack kinase-dead controls, while the substrates neither conform to canonical AGC kinase substrate motifs, nor establish a functional link to development of the corpus callosum.</p><p id="P5">Here, we identify 14-3-3η as an interaction partner of MAST1. We show that 14-3-3η binds specifically to two conserved phosphorylation sites in MAST1, S90 and S161. We identify p21-activated kinase (PAK) as the upstream kinase that phosphorylates MAST1 on S90, and S161 as a regulatory autophosphorylation site. We demonstrate that MAST1 phosphorylated on either S90 or S161 forms a stable complex with 14-3-3η <italic>in vitro</italic>. Using two mouse models of patient-derived MCC-CH-CM mutations, we identify the microtubule-associated protein Tau as a substrate of MAST1 and demonstrate that MAST1 phosphorylates Tau <italic>in vitro</italic>. Finally, we show that MCC-CH-CM-associated disease mutations perturb MAST1 kinase activity either through misfolding of its 4HB domain or disruption of its catalytic site.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>MAST1 interacts with 14-3-3 proteins via S90 and S161</title><p id="P6">To shed light on the function and regulation of the MAST kinases, we first sought to identify MAST1 interactors by affinity-purification mass spectrometry (AP-MS) in HEK293 cells. All MAST1 constructs employed in this study are depicted in <xref ref-type="fig" rid="F1">Figure 1A</xref>. MAST1<sup>DKP</sup>, which includes all three folded domains, was N-terminally tagged with EGFP and overexpressed in HEK293 cells (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Comparison of the EGFP-MAST1-bound proteins with an EGFP-only control revealed a MAST1-dependent 6- to 30-fold enrichment of six 14-3-3 paralogs (η, γ, ε, β, ζ, and θ) (<xref ref-type="fig" rid="F1">Figure 1C</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Files 1</xref>-<xref ref-type="supplementary-material" rid="SD2">2</xref>). 14-3-3 proteins are known to bind specifically to phosphorylated serines <sup><xref ref-type="bibr" rid="R20">20</xref></sup>. Analysis of MAST1’s amino acid sequence by 14-3-3Pred <sup><xref ref-type="bibr" rid="R21">21</xref></sup> revealed two putative 14-3-3 binding motifs <sup><xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref></sup> surrounding S90 and S161. Both sites exhibit near-invariant sequence conservation over 600 million years. To visualize a potential interaction between MAST1 and 14-3-3, we predicted the structure of MAST1<sup>D</sup> and the seven mammalian 14-3-3 isoforms, with a 2:2 stoichiometry implied by the dimeric nature of 14-3-3 proteins. AlphaFold <sup><xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R25">25</xref></sup> generated five near-identical models for each prediction with an RMSD ranging between 0.439 and 4.286, placing the unstructured N-terminal region of MAST1 in the cradle of 14-3-3 (<xref ref-type="fig" rid="F1">Figure 1D</xref>-E; 14-3-3η shown as representative). Superposition of the resulting structure with an experimentally determined structure of 14-3-3η in complex with a bound phospho-peptide <sup><xref ref-type="bibr" rid="R26">26</xref></sup> revealed that either residue S90 (<xref ref-type="fig" rid="F1">Figure 1D</xref>) or S161 (<xref ref-type="fig" rid="F1">Figure 1E</xref>) of MAST1 was consistently placed in the same position as the bound phospho-serine of the ligand.</p><p id="P7">To probe whether the N-terminal region of MAST1 binds to 14-3-3, we compared truncation constructs of MAST1 lacking S90, or both S90 and S161 (<xref ref-type="fig" rid="F1">Figure 1B</xref>). By performing pairwise comparison of the interactomes of the truncation constructs, we observed significant enrichment of six 14-3-3 paralogs by MAST1<sup>DKP</sup> when compared to either MAST1<sup>DKP</sup> ΔS90 (<xref ref-type="supplementary-material" rid="SD5">Figure S1A</xref>) or MAST1<sup>DKP</sup> ΔS90 ΔS161 (<xref ref-type="supplementary-material" rid="SD5">Figure S1B</xref>). To determine the site specificity of the interaction, we next performed AP-MS comparisons between MAST1<sup>DKP</sup> WT and S90A or S161A point mutants. Mutation of either S90 or S161 resulted in a significant loss of 14-3-3 binding to MAST1 (<xref ref-type="fig" rid="F1">Figure 1F-G</xref>), while double mutation of both residues resulted in an apparently synergistic loss of 14-3-3 proteins (<xref ref-type="fig" rid="F1">Figure 1H</xref>). The absence of 14-3-3 enrichment in MAST1<sup>DKP</sup> ΔS90, which includes S161 but not S90 (<xref ref-type="fig" rid="F1">Figure 1I</xref>), suggests that 14-3-3 binding to S161 is dependent on 14-3-3 first binding to S90. 14-3-3η was reproducibly the most highly enriched paralog of the six, despite having the lowest abundance in HEK293 cells <sup><xref ref-type="bibr" rid="R27">27</xref></sup> (<xref ref-type="supplementary-material" rid="SD5">Figure S1C</xref>).</p><p id="P8">We further confirmed the interaction between purified 14-3-3η to MAST1 by determining its binding affinity to phosphorylated peptides corresponding to the S90 and S161 motifs <italic>in vitro</italic> (<xref ref-type="fig" rid="F1">Figure 1J</xref>). We confirmed the correct mass of all recombinant proteins and derivatives thereof employed in this study by mass spectrometry (<xref ref-type="supplementary-material" rid="SD5">Figure S2</xref>). Consistent with the AP-MS results, 14-3-3η bound to both phospho-S90 (p-S90) and phospho-S161 (p-S161) peptides, but neither to their unphosphorylated counterparts nor a phosphopeptide with a scrambled amino acid sequence. 14-3-3θ, which exhibited the lowest enrichment by AP-MS, bound MAST1 phosphopeptides with a correspondingly lower affinity.</p><p id="P9">Finally, single cell sequencing has shown that MAST1 and 14-3-3η are expressed simultaneously in developing cortical neurons in mice <sup><xref ref-type="bibr" rid="R28">28</xref></sup> (<xref ref-type="supplementary-material" rid="SD5">Figure S3A-D</xref>). In summary, 14-3-3η binds to MAST1 phosphorylated on either S90 or S161.</p></sec><sec id="S4"><title>PAK4 phosphorylates MAST1 on S90</title><p id="P10">The phosphorylation-dependent interaction of MAST1 with 14-3-3η immediately begs the question of which kinase(s) phosphorylate S90 and S161. To identify candidate upstream kinases for the conserved S90 site (<xref ref-type="fig" rid="F2">Figure 2A</xref>), we employed the ScoreSite prediction algorithm <sup><xref ref-type="bibr" rid="R29">29</xref></sup>, which identified PAK4-6 as the highest ranked kinases (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Curiously, we observed significant enrichment of PAK4 in all AP-MS experiments involving MAST1 S90A (<xref ref-type="fig" rid="F1">Figure 1F, 1H</xref>), suggesting that endogenous PAK4 may have been trapped on a non-phosphorylatable substrate. While PAK4 is relatively abundant in HEK293 cells (280 nM), PAK5 and PAK6 are not detected <sup><xref ref-type="bibr" rid="R30">30</xref></sup> (<xref ref-type="supplementary-material" rid="SD5">Figure S4A</xref>). PAK4-6 are group II PAKs with a consensus motif that differs from group I PAKs (PAK1-3) at positions P+2 and P+3 (<xref ref-type="supplementary-material" rid="SD5">Figure S4B</xref>). PAK4-6 recognize an alanine at the P+2 position, in contrast to the tyrosine or phospho-tyrosine favored by PAK1-3, and PAK4 has a strong preference for a serine at the P+3 position <sup><xref ref-type="bibr" rid="R31">31</xref></sup>. The S90 motif of MAST1 encodes alanine and serine in the P+2 and P+3 positions respectively (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Consistent with PAK4 being the upstream kinase of MAST1 in HEK293 cells, we observed that purified, recombinant PAK4 phosphorylates MAST1<sup>D</sup> in an <italic>in vitro</italic> radiometric kinase assay while a kinase-dead mutant did not (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Mass spectrometry analysis revealed that S90 was phosphorylated with the highest spectral count (<xref ref-type="fig" rid="F2">Figure 2D-E</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary File 3</xref>). We also observed S77 to be phosphorylated, likely due to the similarity in the surrounding amino acid sequence. Single cell RNA sequencing data of the developing mouse brain shows a significant overlap in the transcripts of MAST1 and PAK6, whereas PAK4 is barely detected and PAK5 is not detected at all (<xref ref-type="supplementary-material" rid="SD5">Figure S4C-H</xref>). These findings imply that a group II PAK is an upstream regulator of MAST1 signaling in the developing cortex, with PAK6 being the strongest candidate.</p></sec><sec id="S5"><title>MAST1 S161 is an autoregulatory motif</title><p id="P11">Having identified the upstream kinase for S90, we next sought to identify the kinase that phosphorylates S161. Inspection of the conserved motif surrounding S161 (<xref ref-type="fig" rid="F3">Figure 3A</xref>) revealed the presence of a canonical AGC kinase consensus sequence, characterized by arginine in the P-5 and P-3 positions, as well as a large hydrophobic residue in the P+1 position (<xref ref-type="fig" rid="F3">Figure 3B</xref>) <sup><xref ref-type="bibr" rid="R11">11</xref></sup>. This motif is near invariant in all MAST kinases (<xref ref-type="fig" rid="F3">Figure 3C</xref>), implying an evolutionarily conserved function. Since MAST kinases are, themselves, members of the AGC family, this observation suggested that S161 may represent an autoregulatory phosphorylation site. AlphaFold predictions of a complex between the MAST1 kinase domain and the DUF reproducibly converged on a model that places S161 in the substrate-binding cleft of the kinase domain, canonically poised for phospho-transfer (<xref ref-type="fig" rid="F3">Figure 3D</xref>, <xref ref-type="supplementary-material" rid="SD5">S5A</xref>). In an <italic>in vitro</italic> kinase assay, recombinant MAST1<sup>DK</sup> ΔS90 (<xref ref-type="supplementary-material" rid="SD5">Figure S5B-C</xref>) incubated with ATP was able to autophosphorylate, while a kinase-dead MAST1 was completely inactive (<xref ref-type="fig" rid="F3">Figure 3E-F</xref>). To determine the site-specificity of the reaction, we performed tandem mass spectrometry, which revealed phosphorylation of S161 (<xref ref-type="fig" rid="F3">Figure 3G</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary File 3</xref>). However, the reaction was inefficient and resulted in multiple phosphorylated sites, suggesting that unknown factors may be required for full and specific MAST1 activity. Finally, we measured the binding affinity of MAST1<sup>DK</sup> ΔS90 ΔS161 (<xref ref-type="supplementary-material" rid="SD5">Figure S5D-E</xref>) for a peptide corresponding to the S161 motif (<xref ref-type="fig" rid="F3">Figure 3H</xref>). A peptide bearing the native sequence of MAST1 bound to the kinase with a low affinity consistent with the known strength of kinase-substrate interactions <sup><xref ref-type="bibr" rid="R32">32</xref></sup>.</p><p id="P12">Mutation of the arginines at P-3 and P-5 reduced the binding affinity, which was further reduced by mutation of the leucine in the P+1 position (<xref ref-type="fig" rid="F3">Figure 3H</xref>). These findings are consistent with a specific interaction of the conserved S161 motif with the MAST1 kinase domain. In summary, MAST1 undergoes autophosphorylation at S161, but the factors which control the rate and specificity of the reaction are unknown.</p></sec><sec id="S6"><title>mast1 phosphorylated on S90 or S161 forms a complex with 14-3-3η <italic>in vitro</italic></title><p id="P13">Having established that MAST1 interacts specifically with 14-3-3η in a phosphorylation-dependent manner both in cells and <italic>in vitro</italic>, we sought to reconstitute stable complexes of the purified proteins <italic>in vitro</italic>. To first reconstitute S90-phosphorylated MAST1:14-3-3η, we co-expressed MAST1<sup>DK</sup> with 14-3-3η and PAK4<sup>FL</sup> in baculovirus-infected Sf9 insect cells. Affinity purification of the GST-tagged 14-3-3η yielded a complex with MAST1 which was stable by size-exclusion chromatography (SEC) (<xref ref-type="fig" rid="F4">Figure 4A-B</xref>). Unexpectedly, however, MAST1 was found to be phosphorylated not only on S90 but also on S161 and S163 by tandem mass spectrometry, with higher spectral counts for p-S161 and p-S163 than p-S90 (<xref ref-type="fig" rid="F4">Figure 4C</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary File 3</xref>). The origin and significance of MAST1 phosphorylation on S163 in the insect cells is unclear, but a phospho-peptide corresponding to the S163 motif is incapable of binding to 14-3-3η (<xref ref-type="supplementary-material" rid="SD5">Figure S6A</xref>). Therefore, the complex of MAST1 and 14-3-3η isolated from insect cells co-expressing PAK4 is mediated by phosphorylation of S90, S161, or a combination of both. This suggests that PAK4-mediated MAST1 phosphorylation on S90 promotes the acquisition of p-S161, presumably by autophosphorylation, but this will require further investigation. To determine the stoichiometry of the complex, we measured the mass of the particles by mass photometry <sup><xref ref-type="bibr" rid="R33">33</xref></sup>. Unfortunately, at the concentrations required for mass photometry, the complex dissociated into its constituent components (<xref ref-type="supplementary-material" rid="SD5">Figure S6B</xref>). We therefore employed glutaraldehyde cross-linking to stabilize the complex (<xref ref-type="supplementary-material" rid="SD5">Figure S6C</xref>) and measure its stoichiometry. Particles of MAST1 and 14-3-3η were observed to have an average mass of 132 kDa, which corresponds to a 1:2 complex (<xref ref-type="fig" rid="F4">Figure 4D</xref>, <xref ref-type="supplementary-material" rid="SD5">Figure S6D-F</xref>). The 1:2 stoichiometry was further supported by gel densitometry analysis of the complex in <xref ref-type="fig" rid="F4">Figure 4B</xref>.</p><p id="P14">Since efforts to obtain S90-phosphorylated MAST1 in complex with 14-3-3η by co-expression with PAK4 yielded complexes with a mixture of S90- and S161-phosphorylated MAST1, we reconstituted the S90-phosphorylated MAST1:14-3-3η complex <italic>in vitro</italic> to assess its stoichiometry. Purified MAST1<sup>D</sup>, phosphorylated with PAK4<sup>FL</sup> and subsequently incubated with 14-3-3η at a 1:1 stoichiometry, was purified by analytical SEC (<xref ref-type="fig" rid="F4">Figure 4E</xref>). Complex formation was evidenced by the increase in hydrodynamic radius of MAST1 and the co-elution of the two proteins. Gel densitometry of the co-eluting peak again indicated a 1:2 complex (<xref ref-type="fig" rid="F4">Figure 4F</xref>). This was confirmed by glutaraldehyde cross-linking mass photometry, where particles of S90-phosphorylated MAST1 crosslinked to 14-3-3η were observed to have an average mass of 90 kDa, corresponding to a 1:2 complex (<xref ref-type="fig" rid="F4">Figure 4G</xref>, <xref ref-type="supplementary-material" rid="SD5">Figure S6D, G-H</xref>). In summary, we could reconstitute MAST1:14-3-3η complexes <italic>in vitro</italic>, mediated by either S90 and S161 phosphorylation, and both assemble with a stoichiometry of 1:2.</p></sec><sec id="S7"><title>MAST1 G519S mice exhibit an enlarged corpus callosum</title><p id="P15">To investigate the mechanisms of MCC-CH-CM pathogenicity, we next focused on the molecular consequences of patient-derived MAST1 mutations. MCC-CH-CM patients with heterozygous mutations in MAST1 exhibit gross morphological alterations in their brain structure, with a significantly enlarged corpus callosum <sup><xref ref-type="bibr" rid="R1">1</xref></sup>. Curiously, MAST1 knock-out mice are phenotypically normal <sup><xref ref-type="bibr" rid="R1">1</xref></sup>, implying that the disease is driven by a dominant negative effect of the mutant MAST1 and not by haploinsufficiency. Three of these mutations are triplet deletions in the coding sequence of the 4HB domain and one is a missense mutation in the activation loop of the kinase domain that replaces an invariant glycine in the DFG motif with a serine (<xref ref-type="fig" rid="F5">Figure 5A</xref>). A MAST1<sup>L278del/+</sup> mouse model has previously been generated and exhibits an enlarged corpus callosum and thinner cortex <sup><xref ref-type="bibr" rid="R1">1</xref></sup>. The G517S patient mutation (G519S in mice) has, as yet, not been phenotypically characterized in a mouse model. Using CRISPR-Cas9 genome editing, we generated MAST1<sup>G519S/+</sup> and MAST1<sup>G519S/G519S</sup> mice. Following pronuclear injection with guides targeting exon 14 (<xref ref-type="supplementary-material" rid="SD5">Supplementary Table 1</xref>), founder animals were identified by Sanger sequencing (<xref ref-type="fig" rid="F5">Figure 5B-C</xref>) and backcrossed for 10 generations to C57Bl/6J. G519S homozygotes died shortly after birth, whereas heterozygotes survived into adulthood. Analysis of adult G519S/+ mouse brains by Nissl staining confirmed the presence of an enlarged corpus callosum with a reduction in cortical thickness (<xref ref-type="fig" rid="F5">Figure 5D-F</xref>) consistent with the disease state and the L278del mouse model. It is worth noting that while the phenotypes of the G519S/+ mouse and the previously described L278del/+ mouse are qualitatively similar, the L278del/+ line displays a more pronounced enlargement of the corpus callosum, hinting towards a more severe molecular disruption caused by the L278del mutation. Analysis of MAST protein levels in P0 cortical samples revealed a dose dependent decrease in the levels of MAST1, MAST2 and MAST3 in the G519S/+ mouse compared to +/+ (<xref ref-type="fig" rid="F5">Figure 5G-H</xref>) consistent with a dominant negative mechanism. This implies that the disease phenotype stems from a perturbation of MAST signaling in the developing brain.</p></sec><sec id="S8"><title>Tau is a MAST1 substrate</title><p id="P16">To identify candidate substrates of MAST1, we exploited the previously published MAST1<sup>L278del/L278del</sup> mouse model and the MAST1<sup>G519S/G519S</sup> model generated in this study. To explore how the mutations alter the phosphoproteome in the developing brain we extracted protein lysates from P0 cortices from both controls and homozygotes for the L278del and G519S lines. This time point was selected because the callosal projection neurons are already specified and are extending axons to the contralateral hemisphere <sup><xref ref-type="bibr" rid="R35">35</xref></sup>. Following protein isolation, denaturation, reduction and alkylation, isobaric labels were added and samples were enriched for phosphopeptides using titanium dioxide (TiO2) resin. This resulted in the identification by mass spectrometry of 50601 phosophopeptides in the L278del mouse line and 22192 phosphopeptides in the G519S line, of which 1608 and 610 passed the 5% FDR threshold respectively. A comparative analysis identified 70 phosphopeptides, from 38 proteins, that were observed to be differentially phosphorylated in both L278del and G519S mice when compared to littermate controls (<xref ref-type="fig" rid="F6">Figure 6A</xref>, <xref ref-type="supplementary-material" rid="SD4">Supplementary File 4</xref>). By filtering for hypo-phosphorylated proteins for which the phosphorylated residue was embedded in an AGC kinase consensus motif, we reduced the list of candidate proteins to four (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Of the four candidates, phosphorylation of microtubule-associated protein Tau (MAPT) on S214 was most notable. Tau is a microtubule-associated protein that, like MAST1, is highly expressed in neurons of the developing mouse brain (<xref ref-type="supplementary-material" rid="SD5">Figure S7A-B</xref>) and the phosphorylation state of S214 is considered to be a biomarker for Alzheimer’s Disease (AD) <sup><xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R36">36</xref></sup>. Inspection of the amino acid sequence surrounding S214 revealed that it is near-identical to the S161 autophosphorylation site in MAST1 (<xref ref-type="fig" rid="F6">Figure 6C</xref>). Phosphorylation of Tau on S214 was reduced in both L278del and G519S mice compared to littermate controls (<xref ref-type="fig" rid="F6">Figure 6D-E</xref>).</p><p id="P17">To assess whether MAST1 can phosphorylate Tau <italic>in vitro</italic>, we performed a kinase assay with purified, recombinant Tau (mouse isoform F). The purity and monodispersity of Tau<sup>FL</sup> was confirmed by SEC and mass photometry (<xref ref-type="supplementary-material" rid="SD5">Figure S7C-D</xref>). Wild-type MAST1<sup>DK</sup> ΔS90 phosphorylated Tau, and a kinase-dead mutant of MAST1 was completely inactive against Tau (<xref ref-type="fig" rid="F6">Figure 6F</xref>). However, the speed of the reaction was lower than what would be expected of a fully active AGC kinase. To benchmark this quantitatively, we compared MAST1 phosphorylation of Tau to the catalytic activity of the closely related AGC kinase Myotonic Dystrophy Kinase-Related Cdc42-binding Kinase α (MRCKα), on its substrate myosin light chain 2 (MLC2). MRCKα exhibited a 50-fold higher catalytic efficiency than MAST1 (<xref ref-type="fig" rid="F6">Figure 6G</xref>). The post-translational modification profile of Tau exhibited multiple phosphorylation sites including S214, as well as three known Tau phosphorylation sites <sup><xref ref-type="bibr" rid="R37">37</xref>–<xref ref-type="bibr" rid="R39">39</xref></sup> within its repeat domains (<xref ref-type="fig" rid="F6">Figure 6H</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary File 3</xref>). This phosphorylation pattern is reminiscent of MAST1 autophosphorylation (<xref ref-type="fig" rid="F3">Figure 3F-G</xref>), implying that other factors govern the site-specificity of the reaction. To test whether the catalytic activity of MAST1 is increased when in complex with 14-3-3η, we compared Tau phosphorylation by MAST1<sup>DK</sup> alone or in complex with 14-3-3η, but observed no significant increase (<xref ref-type="supplementary-material" rid="SD5">Figure S7E</xref>).</p><p id="P18">Tau phosphorylated on S214 has previously been reported to bind 14-3-3 proteins <sup><xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R41">41</xref></sup>. Given the similarity of the S214 motif in Tau to the S161 motif in MAST1 and the observation that MAST1 phosphorylated on S161 interacts with 14-3-3η, this is not surprising. We confirmed that purified 14-3-3η binds a phosphorylated peptide of the Tau S214 motif by fluorescence anisotropy (<xref ref-type="fig" rid="F6">Figure 6I</xref>). As previously observed for p-S161, the binding was phosphorylation-dependent and 14-3-3η exhibited a higher affinity than 14-3-3θ. Taken together, these findings support a model in which MAST1 activity plays a role in the regulation of the microtubule cytoskeleton of neurons, via Tau.</p></sec><sec id="S9"><title>MCC-CH-CM mutations perturb MAST1 folding and kinase activity</title><p id="P19">MAST1 proteins in mouse models of patient-derived MCC-CH-CM mutations exert a dominant negative effect by depleting MAST1, 2, and 3 (<xref ref-type="fig" rid="F5">Figure 5H</xref> and Tripathy <italic>et al</italic>. <sup><xref ref-type="bibr" rid="R1">1</xref></sup>). To investigate the molecular basis of pathogenicity, we characterized the effect of the four patient-derived mutations from the original cohort <sup><xref ref-type="bibr" rid="R1">1</xref></sup> <italic>in vitro</italic> (<xref ref-type="fig" rid="F5">Figure 5A</xref>). Since E194, K276 and L278 are all located in α-helices of the 4HB domain (<xref ref-type="fig" rid="F7">Figure 7A</xref>), their deletion would be predicted to induce a register shift in the alpha helix that is incompatible with folding of the 4HB domain. We confirmed that deletion of either E194, K276 or L278 leads to misfolding of MAST1<sup>D</sup> ΔS90 and the formation of insoluble inclusion bodies in <italic>E. coli</italic> (<xref ref-type="fig" rid="F7">Figure 7B</xref>). By contrast, the WT MAST1<sup>D</sup> ΔS90 is almost entirely soluble (<xref ref-type="fig" rid="F7">Figure 7B</xref>, <xref ref-type="supplementary-material" rid="SD5">S8A</xref>). Consistently, expression of a longer construct of MAST1 K276del (MAST1<sup>DK</sup> ΔS90) in Sf9 insect cells resulted in aggregated protein with low yields (<xref ref-type="fig" rid="F7">Figure 7C</xref>, <xref ref-type="supplementary-material" rid="SD5">S8B</xref>).</p><p id="P20">Multiple patients have now been identified with a G517S mutation (mouse G519S), in the kinase domain. Although MAST1<sup>DK</sup> ΔS90 bearing the G519S mutation was properly folded and monomeric by SEC (<xref ref-type="fig" rid="F7">Figure 7D</xref>, <xref ref-type="supplementary-material" rid="SD5">S8C</xref>), it exhibited significantly lower kinase activity against Tau <italic>in vitro</italic>, albeit not completely inactive (<xref ref-type="fig" rid="F7">Figure 7E</xref>). Taken together, these observations show that MCC-CH-CM mutations disrupt the folding and/or catalytic activity of MAST1.</p></sec></sec><sec id="S10" sec-type="discussion"><title>Discussion</title><p id="P21">We have discovered that MAST1 interacts with 14-3-3η in a phosphorylation-specific manner, mediated by S90 and S161. We also identified a group II PAK as the upstream kinase for MAST1 S90 phosphorylation, and S161 as a MAST1 autophosphorylation site. Finally, we provide evidence, both <italic>in vitro</italic> and <italic>in vivo</italic>, that the microtubule-associated protein Tau is a MAST1 substrate.</p><p id="P22">Our finding that PAK phosphorylates MAST1 sheds light on the broader biological pathways that MAST1 may be involved in. Like MAST1, PAK4 is highly expressed during embryogenesis, and is crucial in neurodevelopment, where it regulates the proliferation of neural progenitor cells <sup><xref ref-type="bibr" rid="R42">42</xref></sup>, neuronal differentiation, and migration <sup><xref ref-type="bibr" rid="R43">43</xref></sup>. This stems from PAK4’s role in the Cdc42-dependent reorganization of the actin cytoskeleton <sup><xref ref-type="bibr" rid="R44">44</xref>–<xref ref-type="bibr" rid="R48">48</xref></sup>. Depletion of either Cdc42 or PAK4 results in cell polarity defects in a number of cell types <sup><xref ref-type="bibr" rid="R49">49</xref></sup>, while knockout of PAK4 is embryonic lethal <sup><xref ref-type="bibr" rid="R43">43</xref></sup>. PAK6 activity has been correlated with neurite outgrowth <sup><xref ref-type="bibr" rid="R50">50</xref></sup>, and while PAK5/PAK6 double knockout mice are viable, they exhibit locomotor, learning and memory defects <sup><xref ref-type="bibr" rid="R51">51</xref></sup>. Coordination of the actin cytoskeleton is crucial for axonal growth and steering. Actin and microtubule dynamics are coupled in the peripheral domain of the growth cone, together driving accurate axon navigation <sup><xref ref-type="bibr" rid="R52">52</xref>,<xref ref-type="bibr" rid="R53">53</xref></sup>. Importantly, dysregulation of the growth cone can cause axonal rerouting, resulting in the disruption of axonal fiber tracts such as the corpus callosum <sup><xref ref-type="bibr" rid="R54">54</xref></sup>. Here, Cdc42-activated group II PAKs may link actin polymerization and MAST1-mediated microtubule reorganization. However, the mechanisms that mediate the co-localization of MAST1 and PAK will require further investigation.</p><p id="P23">We have identified S214 of Tau as a MAST1 substrate. Tau binds to microtubules via its microtubule binding domain, encompassing the proline-rich domain (which contains S214) and the repeat domains, allowing Tau to rigidify and stabilize microtubules. Several studies have demonstrated the decreased microtubule binding capacity of Tau p-S214, reducing the stability of axonal microtubules <sup><xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R55">55</xref>,<xref ref-type="bibr" rid="R56">56</xref></sup>. This effect is a combination of a decrease in microtubule binding affinity when Tau is phosphorylated <sup><xref ref-type="bibr" rid="R55">55</xref></sup>, and the sequestration of Tau p-S214 by 14-3-3, which we and others <sup><xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R41">41</xref></sup> have observed. Interestingly, S214 has previously been identified as a cAMP-dependent protein kinase (PKA) phosphorylation site <sup><xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R58">58</xref></sup>. Both PKA and the MAST kinases are AGC kinases, which recognize a conserved substrate consensus motif. It is therefore possible that MAST1 and PKA converge on the same substrate under different cellular conditions. It is also worth noting that, since MAST1 S161 and Tau S214 motifs are near-identical, it is perhaps not surprising that 14-3-3η is a common component in the signaling pathway. Curiously, hyperphosphorylation of S214 is also a marker of Alzheimer’s disease <sup><xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R36">36</xref></sup>, though the significance of the connection to neurodevelopment is unclear. Our data also demonstrates that, at least <italic>in vitro</italic>, MAST1 is capable of phosphorylating Tau on S262, S324 and S356, all of which are reported phosphosites that inhibit microtubule binding <sup><xref ref-type="bibr" rid="R37">37</xref>–<xref ref-type="bibr" rid="R39">39</xref></sup>. Nevertheless, these sites deviate from canonical AGC recognition motifs, so whether MAST1 is the physiologically relevant kinase <italic>in vivo</italic> will require further investigation. Whilst we have not yet explored the implications of MAST1-mediated Tau phosphorylation in the context of neurodevelopment, we hypothesize that MAST1 may negatively regulate microtubule polymerization in neuronal axons to ensure proper formation of the corpus callosum. Indeed, while the loss of Tau alone appears to have little impact on corpus callosum formation, a Tau and MAB1B double-knockout in mice causes a severe reduction in callosal size <sup><xref ref-type="bibr" rid="R57">57</xref></sup>, beyond the more moderate agenesis phenotype observed in MAB1B-only knockout animals <sup><xref ref-type="bibr" rid="R57">57</xref>,<xref ref-type="bibr" rid="R59">59</xref></sup>. This suggests a potential role of Tau in corpus callosum development, which may be partially redundant with MAP1B.</p><p id="P24">By combining these cellular insights with mechanistic insights into the molecular regulation of MAST1, we propose a model for MAST1 signaling (<xref ref-type="fig" rid="F8">Figure 8</xref>). Activated Cdc42 recruits a group II PAK to the plasma membrane, whereupon it phosphorylates MAST1 on S90. MAST1 p-S90 specifically recruits 14-3-3η, expression of which is highly enriched in the brain and ubiquitously expressed in all brain structures <sup><xref ref-type="bibr" rid="R60">60</xref>–<xref ref-type="bibr" rid="R63">63</xref></sup>, forming a complex with 1:2 stoichiometry. Since deletion of the S90 motif results in a loss of 14-3-3 binding to S161, we hypothesize that recruitment of 14-3-3η via p-S90 is required prior to S161 autophosphorylation and subsequent 14-3-3η binding. PAK-mediated phosphorylation of MAST1 S90 could therefore serve to pre-assemble a MAST1:14-3-3η complex. We hypothesize that the p-S90-bound complex is inactive, primed for activation by an unknown cofactor. The binding of a stimulatory cofactor to either MAST1 or the MAST1:14-3-3η complex would trigger MAST1 autophosphorylation at S161, thereby relieving autoinhibition. The consequences of p-S161 displacement from the kinase domain are two-fold: activation of the kinase, and sequestration of p-S161 by 14-3-3η, the latter of which may serve to both prevent reassociation of S161 and protect it from dephosphorylation. Activated MAST1 phosphorylates Tau on S214, causing the dissociation of Tau from microtubules. In short, Cdc42 signaling at the plasma membrane is transduced, through MAST1, to microtubule reorganization and changes in cell morphology.</p><p id="P25">While our findings imply a PAK-dependent coupling between actin and microtubule reorganization via MAST1, there are still many unanswered questions, particularly regarding the mechanism of activation of MAST1. Our data currently do not support a direct role for 14-3-3η in kinase activation, and MAST1 exhibits low activity <italic>in vitro</italic>. These observations beg the obvious question of precisely what role 14-3-3η plays in MAST1 regulation. Like MAST1, the oncoprotein BRAF possesses two regulatory phosphoserines, which simultaneously occupy the binding grooves of a 14-3-3 dimer. This trimeric complex maintains BRAF in an inactive conformation <sup><xref ref-type="bibr" rid="R64">64</xref>,<xref ref-type="bibr" rid="R65">65</xref></sup>, which, upon RAS binding, is converted into an active complex with 2:2 stoichiometry <sup><xref ref-type="bibr" rid="R64">64</xref></sup>. Whilst it is easy to envisage a similar mode of regulation for MAST1, both p-S90 and p-S161-mediated MAST1:14-3-3η complexes were observed to be trimeric, and a tetrameric complex has, so far, not been observed.</p><p id="P26">While the involvement of 14-3-3η in MAST1 signaling is clear, we speculate that there is another, as yet unidentified, factor that drives its activation. AGC kinases, such as MAST, are defined by a ~50 amino acid C-terminal tail containing multiple regulatory motifs, including a hydrophobic motif that allosterically promotes the active conformation <sup><xref ref-type="bibr" rid="R11">11</xref></sup>. In the closely related Dystrophia Myotonica Protein Kinase (DMPK) kinases, the hydrophobic motif is sandwiched in place by dimerization of the N-terminal capped helix bundle domain <sup><xref ref-type="bibr" rid="R66">66</xref>–<xref ref-type="bibr" rid="R69">69</xref></sup>, while the Nuclear Dbf2-related (NDR) kinases are known to depend on MOB1 for activation via a similar mechanism <sup><xref ref-type="bibr" rid="R70">70</xref>–<xref ref-type="bibr" rid="R73">73</xref></sup>. Currently, neither a MAST1-intrinsic domain nor a co-factor has been identified that could fulfil an analogous function. Although inspection of the MAST1 interactome in HEK293s (<xref ref-type="fig" rid="F1">Figure 1C</xref>) failed to reveal any candidate activators by AlphaFold screening, identification of such a factor may depend on the correct cellular context, possibly in differentiated neurons.</p><p id="P27">Finally, this study provides important insights into the molecular consequences of MCC-CH-CM disease-associated mutations. We show that pathogenic mutations in MAST1 perturb folding and/or catalytic activity of the protein. Similar to the L278del mouse mutant, we report that the G519S mutation causes a notable decrease in the protein levels of MAST2, MAST3 and MAST4. Since MAST1 knock-out mice are phenotypically normal, this implies that MCC-CH-CM is the consequence of a dominant negative effect. As 14-3-3 proteins are obligate homodimers, the integration of mutant MAST1 has the potential to poison wild-type MAST complexes, though this would depend on hetero-tetramers of MAST and 14-3-3. Alternatively, the localization of mutant MAST1 to microtubules or titration of essential co-factors may inhibit signaling by wild-type MAST1.</p><p id="P28">In summary, MAST1 is a key regulator of neurodevelopment that potentially links group II PAKs, neuronal regulators of the actin cytoskeleton, to microtubule dynamics. However, several questions surrounding the precise mechanism of MAST1 activation, the origin of the dominant negative effect, and the stoichiometry of 14-3-3η binding remain. Answers to these questions are undoubtedly required to elucidate the physiological role of MAST1 in neurodevelopment as well as its pathological role in MCC-CH-CM.</p></sec><sec id="S11" sec-type="materials | methods" specific-use="web-only"><title>Materials and Methods</title><sec id="S12"><title>EGFP-MAST1 AP-MS</title><p id="P29">N-terminally EGFP-tagged MAST1<sup>DKP</sup> constructs (WT, ΔS90, ΔS90 ΔS161, S90A, S161A, S90A S161A) were cloned into the pEGFP-C1 vector for expression in HEK293 cells and were transfected using Lipofectamine 3000 (Invitrogen). Media on the cells was exchanged 24 h post-transfection and cells were harvested by trypsinization 48 h post-transfection. Cells were lysed with three freeze/thaw cycles in liquid nitrogen, resuspended in lysis buffer (10 mM monosodium phosphate, 40 mM disodium phosphate, 10 mM NaCl, 50 mM NaF, 1 mM TCEP, 10 U Denarase, 1x protease inhibitor cocktail (Sigma P8849), 2 mM benzamidine, 2 mM MgCl2, 0.25% CHAPS, 10 mM betaglycerophosphate, 2 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM EDTA), and incubated at 4°C for 30 min with rotation. Cleared lysates were obtained by centrifuging at 21,000 g, 4°C, for 15 min. Cleared lysates were incubated with GFP-Trap Magnetic beads (Chromotek), incubated at 4°C for 2 h while rotating, washed five times with wash buffer (10 mM monosodium phosphate, 40 mM disodium phosphate, 10 mM NaCl, 50 mM NaF, 1 mM TCEP), and the dry beads were snap-frozen in liquid nitrogen and stored at -80°C, for analysis by mass spectrometry.</p></sec><sec id="S13"><title>Fluorescence anisotropy</title><p id="P30">A 2x serial dilution series was made with purified protein (14-3-3η, 14-3-3θ, or MAST1<sup>DK</sup> ΔS90 ΔS161) and mixed with 50 nM of N-terminally FITC-conjugated peptide and incubated at room temperature for 15 min. The following peptides were used in this study: DGRRWSLASLPSS (MAST1<sup>85-97</sup>), DGRRW{pS}LASLPSS (MAST1<sup>85-97</sup> p-S90), RPRSRSLSPGRSP (MAST1<sup>156-168</sup>), RPRSR{pS}LSPGRSP (MAST1<sup>156-168</sup> p-S161), PLGDP{pS}GRWARLS (MAST1 p-Scramble), RSRSL{pS}PGRSPSS (MAST1<sup>158-170</sup> p-S163), PAVRPRSRSLSPGR (MAST1<sup>153-166</sup> WT), PAVEPESRSLSPGR (MAST1<sup>153-166</sup> R156E R158E), PAVEPESRSDSPGR (MAST1<sup>153-166</sup> R156E R158E L162D), RSRTPSLPTPPTR (Tau<sup>209-221</sup>), and RSRTP{pS}LPTPPTR (Tau<sup>209-221</sup> p-S214). Anisotropy was measured in a 384-well black polystyrene plate on the TECAN Spark Multi-Mode Microplate Reader.</p></sec><sec id="S14"><title>Radiometric kinase assay</title><p id="P31">For substrate phosphorylation assays, 100 nM of kinase was mixed with 25 μM of substrate in assay buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 1 mM TCEP, 2 mM MgCl<sub>2</sub>, 2 mM ATP, 0.25% CHAPS, spiked with 1 μL [γ-32P] ATP/100 μL reaction) and incubated at 23°C for up to 2 h. Aliquots were taken from the reaction volume and quenched with 80 mM EDTA over a time course, then equal volumes of each sample were subjected to SDS-PAGE. The gels were washed three times in dH<sub>2</sub>0, dried, exposed to a phosphor screen for 4 h, and imaged with an Amersham Typhoon imager (Cytiva). Densitometry was performed using ImageJ to quantify the bands of phosphorylated substrate. An internal standard was made by spotting 0.5, 1, 5, and 20 pmol of ATP from the reaction onto a strip of Whatman paper. The standards were also measured with densitometry and used to calculate the total mol of phosphorylated substrate in each sample.</p><p id="P32">For autophosphorylation assays, 50 nM, 150 nM, and 500 nM of MAST1<sup>DK</sup> ΔS90 (WT and D499N) was incubated in assay buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 1 mM TCEP, 2 mM MgCl<sub>2</sub>, 2 mM ATP, 0.25% CHAPS, spiked with 1 μL [γ-32P] ATP/100 μL reaction) at 23°C for up to 2 h. Aliquots were taken from the reaction volume and quenched with 80 mM EDTA over a time course, then equal volumes of each sample were spotted onto a 0.45 μm nitrocellulose membrane. The membrane was washed five times with 20 mL of 75 mM H<sub>3</sub>PO<sub>4</sub>, and exposed and imaged as described above. An internal standard and densitometry were performed as described above.</p></sec><sec id="S15"><title>Analytical size exclusion chromatography</title><p id="P33">A Superdex 200 Increase 3.2/300 size exclusion column (Cytiva) was connected to an Äkta Pure with a Micro configuration (Cytiva) and equilibrated in buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 1 mM TCEP) at 4°C. 50 μL of 30 μM protein samples were centrifuged at 21,000 g for 5 min prior to injection onto the column. For the MAST1<sup>D</sup> p-S90 and 14-3-3η complex formed <italic>in vitro</italic>, equimolar concentrations of each protein were mixed and incubated for 30 min at room temperature prior to injection. 50 μL fractions were collected from each run for analysis by Coomassie-stained SDS-PAGE.</p></sec><sec id="S16"><title>Mass photometry</title><p id="P34">Purified protein samples were clarified after thawing by centrifugation at 21,000 g, 4°C for 5 min and diluted to 0.5 μM in freshly filtered buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 1mM TCEP). Measurements of 60 s duration were recorded at a final concentration of 25-50 nM on microscopy coverslips that were cleaned by sonication in water and isopropanol. All measurements were recorded using a Two<sup>MP</sup> mass photometer (Refeyn) and analyzed using Discover MP (Refeyn). Protein mass was calculated using a contrast-to-mass calibration with NativeMark Protein Standard (Invitrogen).</p></sec><sec id="S17"><title>Histological analysis of mice</title><p id="P35">Adult brains were isolated after transcardial perfusion with 0.9% NaCl followed by 4% PFA for 5 min at a flow rate of approx. 6 mL per minute. Brains were dissected and post-fixed in 4% PFA overnight at 4°C. Brains were washed with PBS and cryoprotected in 30% Sucrose in PBS. For sectioning, brains were embedded in Neg-50™ Medium (Richard-Allan Scientific) and sectioned into 40 µM-thick coronal brain sections using a sledge microtome. Nissl stainings were carried out via incubation in a 0.25% solution of Cresyl Violet acetate (Sigma, #C5042), followed by dehydration in a graded ethanol series (30%, 70%, 95%, 100%; 3 min, 2 min, 30 s, 10 s) and xylol (2 x 2 min) and mounted using DPX mountant (Fluka, #44581). Slides were left to solidify overnight at RT and images were acquired using a Mirax slide scanner (Zeiss). The thickness of the corpus callosum was measured at Bregma + 0.86 mm by performing 3 parallel measurements near the midline position using ImageJ. The cortical thickness was measured at Bregma -1.82 mm through bilateral measurements of the somatosensory cortex at 3 matched positions. Averages were taken and used for analysis.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary File 1</label><media xlink:href="EMS207146-supplement-Supplementary_File_1.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d20aAcEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary File 2</label><media xlink:href="EMS207146-supplement-Supplementary_File_2.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d20aAcEcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Supplementary File 3</label><media xlink:href="EMS207146-supplement-Supplementary_File_3.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d20aAcEdB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Supplementary File 4</label><media xlink:href="EMS207146-supplement-Supplementary_File_4.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d20aAcEeB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Supplementary Information</label><media xlink:href="EMS207146-supplement-Supplementary_Information.pdf" mimetype="application" mime-subtype="pdf" id="d20aAcEfB" position="anchor"/></supplementary-material></sec></body><back><ack id="S18"><title>Acknowledgements</title><p>Proteomics analyses were performed on instruments of the Vienna BioCenter Core Facilities (VBCF). We acknowledge members of the Leonard lab for constructive feedback on the manuscript. This work was funded by Austrian Science Fund (FWF) grants P33066, P6212, P36724, and W1261 to T.A.L. We thank Boehringer Ingelheim for funding basic research and the core facilities at the Institute for Molecular Pathology, and Ludwig-Maximilians-University. P.H is supported by the Studienstiftung des deutschen Volkes.</p></ack><fn-group><fn id="FN1" fn-type="con"><p id="P36">Author Contributions</p><p id="P37">S.A., P.H., D.A.K. and T.A.L. designed the experiments. S.A. performed all experiments reported in this manuscript with the exception of: proteomics analyses (W.C., D.A., M.H., K.M., G.D.); generation of mouse lines (P.H., R.T., M.F.M.R.); preparation of mouse brain samples for phosphoproteomics (P.H., R.T., M.F.M.R.); analysis of G519S mouse line (P.H.). D.A.K. and T.A.L. obtained funding for the project. S.A., P.H. D.A.K., and T.A.L. wrote the manuscript. All authors commented on the manuscript.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathy</surname><given-names>R</given-names></name><name><surname>Leca</surname><given-names>I</given-names></name><name><surname>van Dijk</surname><given-names>T</given-names></name><name><surname>Weiss</surname><given-names>J</given-names></name><name><surname>van Bon</surname><given-names>BW</given-names></name><name><surname>Sergaki</surname><given-names>MC</given-names></name><name><surname>Gstrein</surname><given-names>T</given-names></name><name><surname>Breuss</surname><given-names>M</given-names></name><name><surname>Tian</surname><given-names>G</given-names></name><name><surname>Bahi-Buisson</surname><given-names>N</given-names></name><etal/></person-group><article-title>Mutations in MAST1 Cause Mega-Corpus-Callosum Syndrome with Cerebellar Hypoplasia and Cortical Malformations</article-title><source>Neuron</source><year>2018</year><comment>0</comment><pub-id pub-id-type="doi">10.1016/j.neuron.2018.10.044</pub-id><pub-id pub-id-type="pmcid">PMC6436622</pub-id><pub-id pub-id-type="pmid">30449657</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-García</surname><given-names>ME</given-names></name><name><surname>Cotrina-Vinagre</surname><given-names>FJ</given-names></name><name><surname>Gómez-Cano</surname><given-names>M de LÁ</given-names></name><name><surname>Martínez de Aragón</surname><given-names>A</given-names></name><name><surname>Martín-Hernández</surname><given-names>E</given-names></name><name><surname>Martínez-Azorín</surname><given-names>F</given-names></name></person-group><article-title>MAST1 variant causes mega-corpus-callosum syndrome with cortical malformations but without cerebellar hypoplasia</article-title><source>Am J Med Genet A</source><year>2020</year><volume>182</volume><fpage>1483</fpage><lpage>1490</lpage><pub-id pub-id-type="pmid">32198973</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMichael</surname><given-names>G</given-names></name><name><surname>Bainbridge</surname><given-names>MN</given-names></name><name><surname>Haan</surname><given-names>E</given-names></name><name><surname>Corbett</surname><given-names>M</given-names></name><name><surname>Gardner</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>S</given-names></name><name><surname>van Bon</surname><given-names>BWM</given-names></name><name><surname>van Eyk</surname><given-names>CL</given-names></name><name><surname>Broadbent</surname><given-names>J</given-names></name><name><surname>Reynolds</surname><given-names>C</given-names></name><etal/></person-group><article-title>Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy</article-title><source>Mol Psychiatry</source><year>2015</year><volume>20</volume><fpage>176</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">25666757</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Mahmoud</surname><given-names>A</given-names></name><name><surname>Al-Shamsi</surname><given-names>AM</given-names></name><name><surname>Ali</surname><given-names>BR</given-names></name><name><surname>Al-Gazali</surname><given-names>L</given-names></name></person-group><article-title>Evaluating the Role of MAST1 as an Intellectual Disability Disease Gene: Identification of a Novel De Novo Variant in a Patient with Developmental Disabilities</article-title><source>J Mol Neurosci</source><year>2020</year><volume>70</volume><fpage>320</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">31721002</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hecher</surname><given-names>L</given-names></name><name><surname>Johannsen</surname><given-names>J</given-names></name><name><surname>Bierhals</surname><given-names>T</given-names></name><name><surname>Buhk</surname><given-names>JH</given-names></name><name><surname>Hempel</surname><given-names>M</given-names></name><name><surname>Denecke</surname><given-names>J</given-names></name></person-group><article-title>The Clinical Picture of a Bilateral Perisylvian Syndrome as the Initial Symptom of Mega-Corpus-Callosum Syndrome due to a MAST1-Gene Mutation</article-title><source>Neuropediatrics</source><year>2020</year><volume>51</volume><fpage>435</fpage><lpage>439</lpage><pub-id pub-id-type="pmid">32818970</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinelli</surname><given-names>E</given-names></name><name><surname>Christensen</surname><given-names>KR</given-names></name><name><surname>Bryant</surname><given-names>E</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Rakotomamonjy</surname><given-names>J</given-names></name><name><surname>Muir</surname><given-names>AM</given-names></name><name><surname>Giannelli</surname><given-names>J</given-names></name><name><surname>Littlejohn</surname><given-names>RO</given-names></name><name><surname>Roeder</surname><given-names>ER</given-names></name><name><surname>Schmidt</surname><given-names>B</given-names></name><etal/></person-group><article-title>Pathogenic MAST3 Variants in the STK Domain Are Associated with Epilepsy</article-title><source>Ann Neurol</source><year>2021</year><volume>90</volume><fpage>274</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1002/ana.26147</pub-id><pub-id pub-id-type="pmcid">PMC8324566</pub-id><pub-id pub-id-type="pmid">34185323</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>N</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><etal/></person-group><article-title>The Role of Microtubule Associated Serine/Threonine Kinase 3 Variants in Neurodevelopmental Diseases: Genotype-Phenotype Association</article-title><source>Front Mol Neurosci</source><year>2022</year><volume>14</volume><fpage>326</fpage><pub-id pub-id-type="doi">10.3389/fnmol.2021.775479</pub-id><pub-id pub-id-type="pmcid">PMC8790505</pub-id><pub-id pub-id-type="pmid">35095415</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>N</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Lian</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Xiao</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><etal/></person-group><article-title>De novo variants in MAST4 related to neurodevelopmental disorders with developmental delay and infantile spasms: Genotype-phenotype association</article-title><source>Front Mol Neurosci</source><year>2023</year><volume>16</volume><elocation-id>1097553</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2023.1097553</pub-id><pub-id pub-id-type="pmcid">PMC9992645</pub-id><pub-id pub-id-type="pmid">36910266</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landoulsi</surname><given-names>Z</given-names></name><name><surname>Laatar</surname><given-names>F</given-names></name><name><surname>Noé</surname><given-names>E</given-names></name><name><surname>Mrabet</surname><given-names>S</given-names></name><name><surname>Ben Djebara</surname><given-names>M</given-names></name><name><surname>Achaz</surname><given-names>G</given-names></name><name><surname>Nava</surname><given-names>C</given-names></name><name><surname>Baulac</surname><given-names>S</given-names></name><name><surname>Kacem</surname><given-names>I</given-names></name><name><surname>Gargouri-Berrechid</surname><given-names>A</given-names></name><etal/></person-group><article-title>Clinical and genetic study of Tunisian families with genetic generalized epilepsy: contribution of CACNA1H and MAST4 genes</article-title><source>Neurogenetics</source><year>2018</year><volume>19</volume><fpage>165</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">29948376</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martín-Durán</surname><given-names>JM</given-names></name><name><surname>Hejnol</surname><given-names>A</given-names></name></person-group><article-title>A developmental perspective on the evolution of the nervous system</article-title><source>Dev Biol</source><year>2021</year><volume>475</volume><fpage>181</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">31610146</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname><given-names>LR</given-names></name><name><surname>Komander</surname><given-names>D</given-names></name><name><surname>Alessi</surname><given-names>DR</given-names></name></person-group><article-title>The nuts and bolts of AGC protein kinases</article-title><source>Nat Rev Mol Cell Biol</source><year>2010</year><volume>11</volume><fpage>9</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">20027184</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhardt</surname><given-names>R</given-names></name><name><surname>Leonard</surname><given-names>TA</given-names></name></person-group><article-title>A critical evaluation of protein kinase regulation by activation loop autophosphorylation</article-title><source>Elife</source><year>2023</year><volume>12</volume><pub-id pub-id-type="doi">10.7554/eLife.88210</pub-id><pub-id pub-id-type="pmcid">PMC10359097</pub-id><pub-id pub-id-type="pmid">37470698</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lumeng</surname><given-names>C</given-names></name><name><surname>Phelps</surname><given-names>S</given-names></name><name><surname>Crawford</surname><given-names>GE</given-names></name><name><surname>Walden</surname><given-names>PD</given-names></name><name><surname>Barald</surname><given-names>K</given-names></name><name><surname>Chamberlain</surname><given-names>JS</given-names></name></person-group><article-title>Interactions between β2-syntrophin and a family of microtubule-associated serine/threonine kinases</article-title><source>Nat Neurosci</source><year>1999</year><volume>2</volume><fpage>611</fpage><lpage>617</lpage><pub-id pub-id-type="pmid">10404183</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garland</surname><given-names>P</given-names></name><name><surname>Quraishe</surname><given-names>S</given-names></name><name><surname>French</surname><given-names>P</given-names></name><name><surname>O’Connor</surname><given-names>V</given-names></name></person-group><article-title>Expression of the MAST family of serine/threonine kinases</article-title><source>Brain Res</source><year>2008</year><volume>1195</volume><fpage>12</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">18206861</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delhommel</surname><given-names>F</given-names></name><name><surname>Chaffotte</surname><given-names>A</given-names></name><name><surname>Terrien</surname><given-names>E</given-names></name><name><surname>Raynal</surname><given-names>B</given-names></name><name><surname>Buc</surname><given-names>H</given-names></name><name><surname>Delepierre</surname><given-names>M</given-names></name><name><surname>Cordier</surname><given-names>F</given-names></name><name><surname>Wolff</surname><given-names>N</given-names></name></person-group><article-title>Deciphering the unconventional peptide binding to the PDZ domain of MAST2</article-title><source>Biochem J</source><year>2015</year><volume>469</volume><fpage>159</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">25942057</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terrien</surname><given-names>E</given-names></name><name><surname>Chaffotte</surname><given-names>A</given-names></name><name><surname>Lafage</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>Z</given-names></name><name><surname>Préhaud</surname><given-names>C</given-names></name><name><surname>Cordier</surname><given-names>F</given-names></name><name><surname>Simenel</surname><given-names>C</given-names></name><name><surname>Delepierre</surname><given-names>M</given-names></name><name><surname>Buc</surname><given-names>H</given-names></name><name><surname>Lafon</surname><given-names>M</given-names></name><etal/></person-group><article-title>Interference with the PTEN-MAST2 interaction by a viral protein leads to cellular relocalization of PTEN</article-title><source>Sci Signal</source><year>2012</year><volume>5</volume><elocation-id>ra58</elocation-id><pub-id pub-id-type="pmid">22894835</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valiente</surname><given-names>M</given-names></name><name><surname>Andrés-Pons</surname><given-names>A</given-names></name><name><surname>Gomar</surname><given-names>B</given-names></name><name><surname>Torres</surname><given-names>J</given-names></name><name><surname>Gil</surname><given-names>A</given-names></name><name><surname>Tapparel</surname><given-names>C</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name><name><surname>Pulido</surname><given-names>R</given-names></name></person-group><article-title>Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>28936</fpage><lpage>28943</lpage><pub-id pub-id-type="pmid">15951562</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Chun</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>R</given-names></name><name><surname>Alesi</surname><given-names>GN</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>HB</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><etal/></person-group><article-title>MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation</article-title><source>Cancer Cell</source><year>2018</year><volume>34</volume><fpage>315</fpage><lpage>330</lpage><elocation-id>e7</elocation-id><pub-id pub-id-type="doi">10.1016/j.ccell.2018.06.012</pub-id><pub-id pub-id-type="pmcid">PMC6092215</pub-id><pub-id pub-id-type="pmid">30033091</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>EC</given-names></name><name><surname>Musante</surname><given-names>V</given-names></name><name><surname>Horiuchi</surname><given-names>A</given-names></name><name><surname>Matsuzaki</surname><given-names>H</given-names></name><name><surname>Brody</surname><given-names>AH</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name><name><surname>Taylor</surname><given-names>JR</given-names></name><name><surname>Nairn</surname><given-names>AC</given-names></name></person-group><article-title>ARPP-16 Is a Striatal-Enriched Inhibitor of Protein Phosphatase 2A Regulated by Microtubule-Associated Serine/Threonine Kinase 3 (Mast 3 Kinase)</article-title><source>J Neurosci</source><year>2017</year><volume>37</volume><fpage>2709</fpage><lpage>2722</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4559-15.2017</pub-id><pub-id pub-id-type="pmcid">PMC5354324</pub-id><pub-id pub-id-type="pmid">28167675</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muslin</surname><given-names>AJ</given-names></name><name><surname>Tanner</surname><given-names>JW</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name><name><surname>Shaw</surname><given-names>AS</given-names></name></person-group><article-title>Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine</article-title><source>Cell</source><year>1996</year><volume>84</volume><fpage>889</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">8601312</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madeira</surname><given-names>F</given-names></name><name><surname>Tinti</surname><given-names>M</given-names></name><name><surname>Murugesan</surname><given-names>G</given-names></name><name><surname>Berrett</surname><given-names>E</given-names></name><name><surname>Stafford</surname><given-names>M</given-names></name><name><surname>Toth</surname><given-names>R</given-names></name><name><surname>Cole</surname><given-names>C</given-names></name><name><surname>MacKintosh</surname><given-names>C</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><article-title>14-3-3-Pred: improved methods to predict 14-3-3-binding phosphopeptides</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>2276</fpage><lpage>2283</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv133</pub-id><pub-id pub-id-type="pmcid">PMC4495292</pub-id><pub-id pub-id-type="pmid">25735772</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaffe</surname><given-names>MB</given-names></name><name><surname>Rittinger</surname><given-names>K</given-names></name><name><surname>Volinia</surname><given-names>S</given-names></name><name><surname>Caron</surname><given-names>PR</given-names></name><name><surname>Aitken</surname><given-names>A</given-names></name><name><surname>Leffers</surname><given-names>H</given-names></name><name><surname>Gamblin</surname><given-names>SJ</given-names></name><name><surname>Smerdon</surname><given-names>SJ</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name></person-group><article-title>The structural basis for 14-3-3:phosphopeptide binding specificity</article-title><source>Cell</source><year>1997</year><volume>91</volume><fpage>961</fpage><lpage>971</lpage><pub-id pub-id-type="pmid">9428519</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Crowther</surname><given-names>S</given-names></name><name><surname>Stafford</surname><given-names>MJ</given-names></name><name><surname>Campbell</surname><given-names>DG</given-names></name><name><surname>Toth</surname><given-names>R</given-names></name><name><surname>MacKintosh</surname><given-names>C</given-names></name></person-group><article-title>Bioinformatic and experimental survey of 14-3-3-binding sites</article-title><source>Biochem J</source><year>2010</year><volume>427</volume><fpage>69</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1042/BJ20091834</pub-id><pub-id pub-id-type="pmcid">PMC2860806</pub-id><pub-id pub-id-type="pmid">20141511</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmcid">PMC8371605</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramson</surname><given-names>J</given-names></name><name><surname>Adler</surname><given-names>J</given-names></name><name><surname>Dunger</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Willmore</surname><given-names>L</given-names></name><name><surname>Ballard</surname><given-names>AJ</given-names></name><name><surname>Bambrick</surname><given-names>J</given-names></name><etal/></person-group><article-title>Accurate structure prediction of biomolecular interactions with AlphaFold 3</article-title><source>Nature</source><year>2024</year><volume>630</volume><fpage>493</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1038/s41586-024-07487-w</pub-id><pub-id pub-id-type="pmcid">PMC11168924</pub-id><pub-id pub-id-type="pmid">38718835</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>WH</given-names></name><name><surname>Sobott</surname><given-names>F</given-names></name><name><surname>Papagrigoriou</surname><given-names>E</given-names></name><name><surname>Robinson</surname><given-names>CV</given-names></name><name><surname>Grossmann</surname><given-names>JG</given-names></name><name><surname>Sundström</surname><given-names>M</given-names></name><name><surname>Doyle</surname><given-names>DA</given-names></name><name><surname>Elkins</surname><given-names>JM</given-names></name></person-group><article-title>Structural basis for protein-protein interactions in the 14-3-3 protein family</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>17237</fpage><lpage>17242</lpage><pub-id pub-id-type="doi">10.1073/pnas.0605779103</pub-id><pub-id pub-id-type="pmcid">PMC1859916</pub-id><pub-id pub-id-type="pmid">17085597</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>NH</given-names></name><name><surname>Cheveralls</surname><given-names>KC</given-names></name><name><surname>Brunner</surname><given-names>AD</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Michaelis</surname><given-names>AC</given-names></name><name><surname>Raghavan</surname><given-names>P</given-names></name><name><surname>Kobayashi</surname><given-names>H</given-names></name><name><surname>Savy</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>JY</given-names></name><name><surname>Canaj</surname><given-names>H</given-names></name><etal/></person-group><article-title>OpenCell: Endogenous tagging for the cartography of human cellular organization</article-title><source>Science</source><year>2022</year><volume>375</volume><pub-id pub-id-type="doi">10.1126/science.abi6983</pub-id><pub-id pub-id-type="pmcid">PMC9119736</pub-id><pub-id pub-id-type="pmid">35271311</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Manno</surname><given-names>G</given-names></name><name><surname>Siletti</surname><given-names>K</given-names></name><name><surname>Furlan</surname><given-names>A</given-names></name><name><surname>Gyllborg</surname><given-names>D</given-names></name><name><surname>Vinsland</surname><given-names>E</given-names></name><name><surname>Mossi Albiach</surname><given-names>A</given-names></name><name><surname>Mattsson Langseth</surname><given-names>C</given-names></name><name><surname>Khven</surname><given-names>I</given-names></name><name><surname>Lederer</surname><given-names>AR</given-names></name><name><surname>Dratva</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Molecular architecture of the developing mouse brain</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>92</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">34321664</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Yaron</surname><given-names>TM</given-names></name><name><surname>Huntsman</surname><given-names>EM</given-names></name><name><surname>Kerelsky</surname><given-names>A</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>TY</given-names></name><name><surname>Liberatore</surname><given-names>K</given-names></name><name><surname>Cizin</surname><given-names>DM</given-names></name><name><surname>Cohen</surname><given-names>BM</given-names></name><etal/></person-group><article-title>An atlas of substrate specificities for the human serine/threonine kinome</article-title><source>Nature</source><year>2023</year><volume>613</volume><fpage>759</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-05575-3</pub-id><pub-id pub-id-type="pmcid">PMC9876800</pub-id><pub-id pub-id-type="pmid">36631611</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hein</surname><given-names>MY</given-names></name><name><surname>Hubner</surname><given-names>NC</given-names></name><name><surname>Poser</surname><given-names>I</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Nagaraj</surname><given-names>N</given-names></name><name><surname>Toyoda</surname><given-names>Y</given-names></name><name><surname>Gak</surname><given-names>IA</given-names></name><name><surname>Weisswange</surname><given-names>I</given-names></name><name><surname>Mansfeld</surname><given-names>J</given-names></name><name><surname>Buchholz</surname><given-names>F</given-names></name><etal/></person-group><article-title>A human interactome in three quantitative dimensions organized by stoichiometries and abundances</article-title><source>Cell</source><year>2015</year><volume>163</volume><fpage>712</fpage><lpage>723</lpage><pub-id pub-id-type="pmid">26496610</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rennefahrt</surname><given-names>UEE</given-names></name><name><surname>Deacon</surname><given-names>SW</given-names></name><name><surname>Parker</surname><given-names>SA</given-names></name><name><surname>Devarajan</surname><given-names>K</given-names></name><name><surname>Beeser</surname><given-names>A</given-names></name><name><surname>Chernoff</surname><given-names>J</given-names></name><name><surname>Knapp</surname><given-names>S</given-names></name><name><surname>Turk</surname><given-names>BE</given-names></name><name><surname>Peterson</surname><given-names>JR</given-names></name></person-group><article-title>Specificity profiling of Pak kinases allows identification of novel phosphorylation sites</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>15667</fpage><lpage>15678</lpage><pub-id pub-id-type="pmid">17392278</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endicott</surname><given-names>JA</given-names></name><name><surname>Noble</surname><given-names>MEM</given-names></name><name><surname>Johnson</surname><given-names>LN</given-names></name></person-group><article-title>The structural basis for control of eukaryotic protein kinases</article-title><source>Annu Rev Biochem</source><year>2012</year><volume>81</volume><fpage>587</fpage><lpage>613</lpage><pub-id pub-id-type="pmid">22482904</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>G</given-names></name><name><surname>Hundt</surname><given-names>N</given-names></name><name><surname>Cole</surname><given-names>D</given-names></name><name><surname>Fineberg</surname><given-names>A</given-names></name><name><surname>Andrecka</surname><given-names>J</given-names></name><name><surname>Tyler</surname><given-names>A</given-names></name><name><surname>Olerinyova</surname><given-names>A</given-names></name><name><surname>Ansari</surname><given-names>A</given-names></name><name><surname>Marklund</surname><given-names>EG</given-names></name><name><surname>Collier</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Quantitative mass imaging of single biological macromolecules</article-title><source>Science</source><year>2018</year><volume>360</volume><fpage>423</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1126/science.aar5839</pub-id><pub-id pub-id-type="pmcid">PMC6103225</pub-id><pub-id pub-id-type="pmid">29700264</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenlon</surname><given-names>LR</given-names></name><name><surname>Richards</surname><given-names>LJ</given-names></name></person-group><article-title>Contralateral targeting of the corpus callosum in normal and pathological brain function</article-title><source>Trends Neurosci</source><year>2015</year><volume>38</volume><fpage>264</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">25841797</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jicha</surname><given-names>GA</given-names></name><name><surname>Weaver</surname><given-names>C</given-names></name><name><surname>Lane</surname><given-names>E</given-names></name><name><surname>Vianna</surname><given-names>C</given-names></name><name><surname>Kress</surname><given-names>Y</given-names></name><name><surname>Rockwood</surname><given-names>J</given-names></name><name><surname>Davies</surname><given-names>P</given-names></name></person-group><article-title>cAMP-dependent protein kinase phosphorylations on tau in Alzheimer’s disease</article-title><source>J Neurosci</source><year>1999</year><volume>19</volume><fpage>7486</fpage><lpage>7494</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-17-07486.1999</pub-id><pub-id pub-id-type="pmcid">PMC6782506</pub-id><pub-id pub-id-type="pmid">10460255</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name></person-group><article-title>Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4/p38delta or JNK2 in the presence of heparin generates the AT100 epitope</article-title><source>J Neurochem</source><year>2006</year><volume>99</volume><fpage>154</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">16987243</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biernat</surname><given-names>J</given-names></name><name><surname>Gustke</surname><given-names>N</given-names></name><name><surname>Drewes</surname><given-names>G</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name></person-group><article-title>Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding</article-title><source>Neuron</source><year>1993</year><volume>11</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">8393323</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Biernat</surname><given-names>J</given-names></name><name><surname>von Bergen</surname><given-names>M</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name></person-group><article-title>Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments</article-title><source>Biochemistry</source><year>1999</year><volume>38</volume><fpage>3549</fpage><lpage>3558</lpage><pub-id pub-id-type="pmid">10090741</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlomagno</surname><given-names>Y</given-names></name><name><surname>Chung</surname><given-names>DEC</given-names></name><name><surname>Yue</surname><given-names>M</given-names></name><name><surname>Castanedes-Casey</surname><given-names>M</given-names></name><name><surname>Madden</surname><given-names>BJ</given-names></name><name><surname>Dunmore</surname><given-names>J</given-names></name><name><surname>Tong</surname><given-names>J</given-names></name><name><surname>DeTure</surname><given-names>M</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><etal/></person-group><article-title>An acetylation-phosphorylation switch that regulates tau aggregation propensity and function</article-title><source>J Biol Chem</source><year>2017</year><volume>292</volume><fpage>15277</fpage><lpage>15286</lpage><pub-id pub-id-type="doi">10.1074/jbc.M117.794602</pub-id><pub-id pub-id-type="pmcid">PMC5602388</pub-id><pub-id pub-id-type="pmid">28760828</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadik</surname><given-names>G</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Yamamori</surname><given-names>H</given-names></name><name><surname>Nessa</surname><given-names>BN</given-names></name><name><surname>Morihara</surname><given-names>T</given-names></name><name><surname>Takeda</surname><given-names>M</given-names></name></person-group><article-title>Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation</article-title><source>J Neurochem</source><year>2009</year><volume>108</volume><fpage>33</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">19014373</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves</surname><given-names>JF</given-names></name><name><surname>Petrvalská</surname><given-names>O</given-names></name><name><surname>Bosica</surname><given-names>F</given-names></name><name><surname>Cantrelle</surname><given-names>F-X</given-names></name><name><surname>Merzougui</surname><given-names>H</given-names></name><name><surname>O’Mahony</surname><given-names>G</given-names></name><name><surname>Hanoulle</surname><given-names>X</given-names></name><name><surname>Obšil</surname><given-names>T</given-names></name><name><surname>Landrieu</surname><given-names>I</given-names></name></person-group><article-title>Phosphorylated full-length Tau interacts with 14-3-3 proteins via two short phosphorylated sequences, each occupying a binding groove of 14-3-3 dimer</article-title><source>FEBS J</source><year>2021</year><volume>288</volume><fpage>1918</fpage><lpage>1934</lpage><pub-id pub-id-type="pmid">32979285</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Lei</surname><given-names>L</given-names></name><name><surname>Minden</surname><given-names>A</given-names></name></person-group><article-title>A key role for Pak4 in proliferation and differentiation of neural progenitor cells</article-title><source>Dev Biol</source><year>2011</year><volume>353</volume><fpage>206</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">21382368</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Novitch</surname><given-names>BG</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Kohn</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>J-M</given-names></name><name><surname>Kozinn</surname><given-names>S</given-names></name><name><surname>Bronson</surname><given-names>R</given-names></name><name><surname>Beg</surname><given-names>AA</given-names></name><name><surname>Minden</surname><given-names>A</given-names></name></person-group><article-title>PAK4 kinase is essential for embryonic viability and for proper neuronal development</article-title><source>Mol Cell Biol</source><year>2003</year><volume>23</volume><fpage>7122</fpage><lpage>7133</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.20.7122-7133.2003</pub-id><pub-id pub-id-type="pmcid">PMC230313</pub-id><pub-id pub-id-type="pmid">14517283</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abo</surname><given-names>A</given-names></name><name><surname>Qu</surname><given-names>J</given-names></name><name><surname>Cammarano</surname><given-names>MS</given-names></name><name><surname>Dan</surname><given-names>C</given-names></name><name><surname>Fritsch</surname><given-names>A</given-names></name><name><surname>Baud</surname><given-names>V</given-names></name><name><surname>Belisle</surname><given-names>B</given-names></name><name><surname>Minden</surname><given-names>A</given-names></name></person-group><article-title>PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia</article-title><source>EMBO J</source><year>1998</year><volume>17</volume><fpage>6527</fpage><lpage>6540</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.22.6527</pub-id><pub-id pub-id-type="pmcid">PMC1171000</pub-id><pub-id pub-id-type="pmid">9822598</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baskaran</surname><given-names>Y</given-names></name><name><surname>Ng</surname><given-names>Y-W</given-names></name><name><surname>Selamat</surname><given-names>W</given-names></name><name><surname>Ling</surname><given-names>FTP</given-names></name><name><surname>Manser</surname><given-names>E</given-names></name></person-group><article-title>Group I and II mammalian PAKs have different modes of activation by Cdc42</article-title><source>EMBO Rep</source><year>2012</year><volume>13</volume><fpage>653</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1038/embor.2012.75</pub-id><pub-id pub-id-type="pmcid">PMC3388789</pub-id><pub-id pub-id-type="pmid">22653441</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>BH</given-names></name><name><surname>Boggon</surname><given-names>TJ</given-names></name></person-group><article-title>CDC42 binds PAK4 via an extended GTPase-effector interface</article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><fpage>531</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1073/pnas.1717437115</pub-id><pub-id pub-id-type="pmcid">PMC5776996</pub-id><pub-id pub-id-type="pmid">29295922</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dan</surname><given-names>C</given-names></name><name><surname>Kelly</surname><given-names>A</given-names></name><name><surname>Bernard</surname><given-names>O</given-names></name><name><surname>Minden</surname><given-names>A</given-names></name></person-group><article-title>Cytoskeletal changes regulated by the PAK4 Serine/threonine kinase are mediated by LIM kinase 1 and cofilin</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>32115</fpage><lpage>32121</lpage><pub-id pub-id-type="pmid">11413130</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etienne-Manneville</surname><given-names>S</given-names></name></person-group><article-title>Cdc42--the centre of polarity</article-title><source>J Cell Sci</source><year>2004</year><volume>117</volume><fpage>1291</fpage><lpage>1300</lpage><pub-id pub-id-type="pmid">15020669</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selamat</surname><given-names>W</given-names></name><name><surname>Tay</surname><given-names>P-LF</given-names></name><name><surname>Baskaran</surname><given-names>Y</given-names></name><name><surname>Manser</surname><given-names>E</given-names></name></person-group><article-title>The Cdc42 effector kinase PAK4 localizes to cell-cell junctions and contributes to establishing cell polarity</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><elocation-id>e0129634</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0129634</pub-id><pub-id pub-id-type="pmcid">PMC4466050</pub-id><pub-id pub-id-type="pmid">26068882</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Civiero</surname><given-names>L</given-names></name><name><surname>Cirnaru</surname><given-names>MD</given-names></name><name><surname>Beilina</surname><given-names>A</given-names></name><name><surname>Rodella</surname><given-names>U</given-names></name><name><surname>Russo</surname><given-names>I</given-names></name><name><surname>Belluzzi</surname><given-names>E</given-names></name><name><surname>Lobbestael</surname><given-names>E</given-names></name><name><surname>Reyniers</surname><given-names>L</given-names></name><name><surname>Hondhamuni</surname><given-names>G</given-names></name><name><surname>Lewis</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain</article-title><source>J Neurochem</source><year>2015</year><volume>135</volume><fpage>1242</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.1111/jnc.13369</pub-id><pub-id pub-id-type="pmcid">PMC4715492</pub-id><pub-id pub-id-type="pmid">26375402</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nekrasova</surname><given-names>T</given-names></name><name><surname>Jobes</surname><given-names>ML</given-names></name><name><surname>Ting</surname><given-names>JH</given-names></name><name><surname>Wagner</surname><given-names>GC</given-names></name><name><surname>Minden</surname><given-names>A</given-names></name></person-group><article-title>Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion</article-title><source>Dev Biol</source><year>2008</year><volume>322</volume><fpage>95</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">18675265</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>AW</given-names></name><name><surname>Kabir</surname><given-names>N</given-names></name><name><surname>Forscher</surname><given-names>P</given-names></name></person-group><article-title>Filopodia and actin arcs guide the assembly and transport of two populations of microtubules with unique dynamic parameters in neuronal growth cones</article-title><source>J Cell Biol</source><year>2002</year><volume>158</volume><fpage>139</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1083/jcb.200203038</pub-id><pub-id pub-id-type="pmcid">PMC2173029</pub-id><pub-id pub-id-type="pmid">12105186</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>TM</given-names></name><name><surname>Letourneau</surname><given-names>PC</given-names></name></person-group><article-title>Actin dynamics in growth cone motility and navigation</article-title><source>J Neurochem</source><year>2014</year><volume>129</volume><fpage>221</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1111/jnc.12506</pub-id><pub-id pub-id-type="pmcid">PMC3980044</pub-id><pub-id pub-id-type="pmid">24164353</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanier</surname><given-names>LM</given-names></name><name><surname>Gates</surname><given-names>MA</given-names></name><name><surname>Witke</surname><given-names>W</given-names></name><name><surname>Menzies</surname><given-names>AS</given-names></name><name><surname>Wehman</surname><given-names>AM</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name><name><surname>Kwiatkowski</surname><given-names>D</given-names></name><name><surname>Soriano</surname><given-names>P</given-names></name><name><surname>Gertler</surname><given-names>FB</given-names></name></person-group><article-title>Mena is required for neurulation and commissure formation</article-title><source>Neuron</source><year>1999</year><volume>22</volume><fpage>313</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">10069337</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Illenberger</surname><given-names>S</given-names></name><name><surname>Zheng-Fischhöfer</surname><given-names>Q</given-names></name><name><surname>Preuss</surname><given-names>U</given-names></name><name><surname>Stamer</surname><given-names>K</given-names></name><name><surname>Baumann</surname><given-names>K</given-names></name><name><surname>Trinczek</surname><given-names>B</given-names></name><name><surname>Biernat</surname><given-names>J</given-names></name><name><surname>Godemann</surname><given-names>R</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name></person-group><article-title>The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer’s disease</article-title><source>Mol Biol Cell</source><year>1998</year><volume>9</volume><fpage>1495</fpage><lpage>1512</lpage><pub-id pub-id-type="doi">10.1091/mbc.9.6.1495</pub-id><pub-id pub-id-type="pmcid">PMC25374</pub-id><pub-id pub-id-type="pmid">9614189</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Chan</surname><given-names>CB</given-names></name><name><surname>Kwon</surname><given-names>I-S</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>H-P</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Sompol</surname><given-names>P</given-names></name><name><surname>Jin</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>H-G</given-names></name><etal/></person-group><article-title>SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer’s disease</article-title><source>J Neurosci</source><year>2012</year><volume>32</volume><fpage>17262</fpage><lpage>17272</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3300-12.2012</pub-id><pub-id pub-id-type="pmcid">PMC3518045</pub-id><pub-id pub-id-type="pmid">23197718</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>SJ</given-names></name><name><surname>Zhang</surname><given-names>JY</given-names></name><name><surname>Li</surname><given-names>HL</given-names></name><name><surname>Fang</surname><given-names>ZY</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Deng</surname><given-names>HM</given-names></name><name><surname>Gong</surname><given-names>CX</given-names></name><name><surname>Grundke-Iqbal</surname><given-names>I</given-names></name><name><surname>Iqbal</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>JZ</given-names></name></person-group><article-title>Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>50078</fpage><lpage>50088</lpage><pub-id pub-id-type="pmid">15375165</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takei</surname><given-names>Y</given-names></name><name><surname>Teng</surname><given-names>J</given-names></name><name><surname>Harada</surname><given-names>A</given-names></name><name><surname>Hirokawa</surname><given-names>N</given-names></name></person-group><article-title>Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes</article-title><source>J Cell Biol</source><year>2000</year><volume>150</volume><fpage>989</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1083/jcb.150.5.989</pub-id><pub-id pub-id-type="pmcid">PMC2175245</pub-id><pub-id pub-id-type="pmid">10973990</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meixner</surname><given-names>A</given-names></name><name><surname>Haverkamp</surname><given-names>S</given-names></name><name><surname>Wässle</surname><given-names>H</given-names></name><name><surname>Führer</surname><given-names>S</given-names></name><name><surname>Thalhammer</surname><given-names>J</given-names></name><name><surname>Kropf</surname><given-names>N</given-names></name><name><surname>Bittner</surname><given-names>RE</given-names></name><name><surname>Lassmann</surname><given-names>H</given-names></name><name><surname>Wiche</surname><given-names>G</given-names></name><name><surname>Propst</surname><given-names>F</given-names></name></person-group><article-title>MAP1B is required for axon guidance and Is involved in the development of the central and peripheral nervous system</article-title><source>J Cell Biol</source><year>2000</year><volume>151</volume><fpage>1169</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1083/jcb.151.6.1169</pub-id><pub-id pub-id-type="pmcid">PMC2190583</pub-id><pub-id pub-id-type="pmid">11121433</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Lassmann</surname><given-names>T</given-names></name><name><surname>Murata</surname><given-names>M</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name></person-group><article-title>5’ end-centered expression profiling using cap-analysis gene expression and next-generation sequencing</article-title><source>Nat Protoc</source><year>2012</year><volume>7</volume><fpage>542</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.005</pub-id><pub-id pub-id-type="pmcid">PMC4094379</pub-id><pub-id pub-id-type="pmid">22362160</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edfors</surname><given-names>F</given-names></name><name><surname>Danielsson</surname><given-names>F</given-names></name><name><surname>Hallström</surname><given-names>BM</given-names></name><name><surname>Käll</surname><given-names>L</given-names></name><name><surname>Lundberg</surname><given-names>E</given-names></name><name><surname>Pontén</surname><given-names>F</given-names></name><name><surname>Forsström</surname><given-names>B</given-names></name><name><surname>Uhlén</surname><given-names>M</given-names></name></person-group><article-title>Gene-specific correlation of RNA and protein levels in human cells and tissues</article-title><source>Mol Syst Biol</source><year>2016</year><volume>12</volume><fpage>883</fpage><pub-id pub-id-type="doi">10.15252/msb.20167144</pub-id><pub-id pub-id-type="pmcid">PMC5081484</pub-id><pub-id pub-id-type="pmid">27951527</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pontén</surname><given-names>F</given-names></name><name><surname>Gry</surname><given-names>M</given-names></name><name><surname>Fagerberg</surname><given-names>L</given-names></name><name><surname>Lundberg</surname><given-names>E</given-names></name><name><surname>Asplund</surname><given-names>A</given-names></name><name><surname>Berglund</surname><given-names>L</given-names></name><name><surname>Oksvold</surname><given-names>P</given-names></name><name><surname>Björling</surname><given-names>E</given-names></name><name><surname>Hober</surname><given-names>S</given-names></name><name><surname>Kampf</surname><given-names>C</given-names></name><etal/></person-group><article-title>A global view of protein expression in human cells, tissues, and organs</article-title><source>Mol Syst Biol</source><year>2009</year><volume>5</volume><fpage>337</fpage><pub-id pub-id-type="doi">10.1038/msb.2009.93</pub-id><pub-id pub-id-type="pmcid">PMC2824494</pub-id><pub-id pub-id-type="pmid">20029370</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlén</surname><given-names>M</given-names></name><name><surname>Fagerberg</surname><given-names>L</given-names></name><name><surname>Hallström</surname><given-names>BM</given-names></name><name><surname>Lindskog</surname><given-names>C</given-names></name><name><surname>Oksvold</surname><given-names>P</given-names></name><name><surname>Mardinoglu</surname><given-names>A</given-names></name><name><surname>Sivertsson</surname><given-names>Å</given-names></name><name><surname>Kampf</surname><given-names>C</given-names></name><name><surname>Sjöstedt</surname><given-names>E</given-names></name><name><surname>Asplund</surname><given-names>A</given-names></name><etal/></person-group><article-title>Tissue-based map of the human proteome</article-title><source>Science</source><year>2015</year><volume>347</volume><elocation-id>1260419</elocation-id><pub-id pub-id-type="pmid">25613900</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>E</given-names></name><name><surname>Rawson</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>BW</given-names></name><name><surname>Ficarro</surname><given-names>SB</given-names></name><name><surname>Pino</surname><given-names>GG-D</given-names></name><name><surname>Sharif</surname><given-names>H</given-names></name><name><surname>Marto</surname><given-names>JA</given-names></name><name><surname>Jeon</surname><given-names>H</given-names></name><name><surname>Eck</surname><given-names>MJ</given-names></name></person-group><article-title>Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes</article-title><source>Nature</source><year>2019</year><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1660-y</pub-id><pub-id pub-id-type="pmcid">PMC7014971</pub-id><pub-id pub-id-type="pmid">31581174</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>Y</given-names></name><name><surname>Ognjenovic</surname><given-names>J</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Karandur</surname><given-names>D</given-names></name><name><surname>Merk</surname><given-names>A</given-names></name><name><surname>Kulhanek</surname><given-names>K</given-names></name><name><surname>Wong</surname><given-names>K</given-names></name><name><surname>Roose</surname><given-names>JP</given-names></name><name><surname>Subramaniam</surname><given-names>S</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name></person-group><article-title>Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases</article-title><source>Science</source><year>2019</year><volume>366</volume><fpage>109</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1126/science.aay0543</pub-id><pub-id pub-id-type="pmcid">PMC7007921</pub-id><pub-id pub-id-type="pmid">31604311</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H</given-names></name><name><surname>Kasa</surname><given-names>M</given-names></name><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name><name><surname>Hakoshima</surname><given-names>T</given-names></name></person-group><article-title>Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil</article-title><source>Structure</source><year>2006</year><volume>14</volume><fpage>589</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">16531242</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heikkila</surname><given-names>T</given-names></name><name><surname>Wheatley</surname><given-names>E</given-names></name><name><surname>Crighton</surname><given-names>D</given-names></name><name><surname>Schroder</surname><given-names>E</given-names></name><name><surname>Boakes</surname><given-names>A</given-names></name><name><surname>Kaye</surname><given-names>SJ</given-names></name><name><surname>Mezna</surname><given-names>M</given-names></name><name><surname>Pang</surname><given-names>L</given-names></name><name><surname>Rushbrooke</surname><given-names>M</given-names></name><name><surname>Turnbull</surname><given-names>A</given-names></name><etal/></person-group><article-title>Co-Crystal Structures of Inhibitors with MRCKβ, a Key Regulator of Tumor Cell Invasion</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><elocation-id>e24825</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0024825</pub-id><pub-id pub-id-type="pmcid">PMC3176812</pub-id><pub-id pub-id-type="pmid">21949762</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komander</surname><given-names>D</given-names></name><name><surname>Garg</surname><given-names>R</given-names></name><name><surname>Wan</surname><given-names>PTC</given-names></name><name><surname>Ridley</surname><given-names>AJ</given-names></name><name><surname>Barford</surname><given-names>D</given-names></name></person-group><article-title>Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure</article-title><source>EMBO J</source><year>2008</year><volume>27</volume><fpage>3175</fpage><lpage>3185</lpage><pub-id pub-id-type="doi">10.1038/emboj.2008.226</pub-id><pub-id pub-id-type="pmcid">PMC2579254</pub-id><pub-id pub-id-type="pmid">18946488</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couzens</surname><given-names>AL</given-names></name><name><surname>Saridakis</surname><given-names>V</given-names></name><name><surname>Scheid</surname><given-names>MP</given-names></name></person-group><article-title>The hydrophobic motif of ROCK2 requires association with the N-terminal extension for kinase activity</article-title><source>Biochem J</source><year>2009</year><volume>419</volume><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">19099536</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devroe</surname><given-names>E</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name><name><surname>Silver</surname><given-names>PA</given-names></name></person-group><article-title>Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>24444</fpage><lpage>24451</lpage><pub-id pub-id-type="pmid">15067004</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bichsel</surname><given-names>SJ</given-names></name><name><surname>Tamaskovic</surname><given-names>R</given-names></name><name><surname>Stegert</surname><given-names>MR</given-names></name><name><surname>Hemmings</surname><given-names>BA</given-names></name></person-group><article-title>Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>35228</fpage><lpage>35235</lpage><pub-id pub-id-type="pmid">15197186</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>BW</given-names></name><name><surname>Gogl</surname><given-names>G</given-names></name><name><surname>Bálint</surname><given-names>M</given-names></name><name><surname>Hetényi</surname><given-names>C</given-names></name><name><surname>Reményi</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>EL</given-names></name></person-group><article-title>Ndr/Lats Kinases Bind Specific Mob-Family Coactivators through a Conserved and Modular Interface</article-title><source>Biochemistry</source><year>2020</year><volume>59</volume><fpage>1688</fpage><lpage>1700</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.9b01096</pub-id><pub-id pub-id-type="pmcid">PMC8341033</pub-id><pub-id pub-id-type="pmid">32250593</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gógl</surname><given-names>G</given-names></name><name><surname>Schneider</surname><given-names>KD</given-names></name><name><surname>Yeh</surname><given-names>BJ</given-names></name><name><surname>Alam</surname><given-names>N</given-names></name><name><surname>Nguyen Ba</surname><given-names>AN</given-names></name><name><surname>Moses</surname><given-names>AM</given-names></name><name><surname>Hetényi</surname><given-names>C</given-names></name><name><surname>Reményi</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>EL</given-names></name></person-group><article-title>The Structure of an NDR/LATS Kinase–Mob Complex Reveals a Novel Kinase–Coactivator System and Substrate Docking Mechanism</article-title><source>PLoS Biol</source><year>2015</year><volume>13</volume><elocation-id>e1002146</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1002146</pub-id><pub-id pub-id-type="pmcid">PMC4428629</pub-id><pub-id pub-id-type="pmid">25966461</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Cron</surname><given-names>P</given-names></name><name><surname>Good</surname><given-names>VM</given-names></name><name><surname>Thompson</surname><given-names>V</given-names></name><name><surname>Hemmings</surname><given-names>BA</given-names></name><name><surname>Barford</surname><given-names>D</given-names></name></person-group><article-title>Crystal structure of an activated Akt/Protein Kinase B ternary complex with GSK3-peptide and AMP-PNP</article-title><source>Nat Struct Biol</source><year>2002</year><volume>9</volume><fpage>940</fpage><lpage>944</lpage><pub-id pub-id-type="pmid">12434148</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>MAST1 interacts with 14-3-3 proteins via S90 and S161.</title><p>A. Domain architecture of <italic>Mus musculus</italic> MAST1. Construct boundaries and nomenclature for all constructs used in this study are defined. DUF = domain of unknown function, 4HB = four-helix bundle, PDZ = postsynaptic density protein (PDS95) Drosophila disc large tumor suppressor (DlgA) and Zonula occludens-1 protein (zo-1). Right: schematic representation of MAST1 to be employed throughout the figures.</p><p>B. Construct boundaries and experimental setup for EGFP-MAST1<sup>DKP</sup> AP-MS in HEK293 cells.</p><p>C. Volcano plot displaying the enriched interactome of EGFP-MAST1<sup>DKP</sup> (right) vs EGFP (left) from AP-MS, <italic>n</italic> = 3.</p><p>D. AlphaFold3 <sup><xref ref-type="bibr" rid="R25">25</xref></sup> model and pair alignment error (PAE) plot of 14-3-3η dimer (red) and MAST1<sup>D</sup> dimer (gold), when region spanning MAST1 S90 (light blue bubble) interacts with 14-3-3 cradle.</p><p>E. AlphaFold3 <sup><xref ref-type="bibr" rid="R25">25</xref></sup> model and PAE plot of 14-3-3η dimer (red) and MAST1<sup>D</sup> dimer (gold), when region spanning MAST1 S161 (dark blue bubble) interacts with 14-3-3 cradle.</p><p>F. Volcano plot displaying the enriched interactome of EGFP-MAST1<sup>DKP</sup> WT (right) vs EGFP-MAST1<sup>DKP</sup> S90A (left) from AP-MS, <italic>n</italic> = 3.</p><p>G. Volcano plot displaying the enriched interactome of EGFP-MAST1<sup>DKP</sup> WT (right) vs EGFP-MAST1<sup>DKP</sup> S161A (left) from AP-MS, <italic>n</italic> = 3.</p><p>H. Volcano plot displaying the enriched interactome of EGFP-MAST1<sup>DKP</sup> WT (right) vs EGFP-MAST1<sup>DKP</sup> S90A S161A (left) from AP-MS, <italic>n</italic> = 3.</p><p>I. Volcano plot displaying the enriched interactome of EGFP-MAST1<sup>DKP</sup> ΔS90 (right) vs EGFP-MAST1<sup>DKP</sup> ΔS90 ΔS161 (left) from AP-MS, <italic>n</italic> = 3.</p><p>J. Binding curves for 14-3-3η or θ and MAST1 peptides spanning S90 or S161, measured by fluorescence anisotropy. Data are presented as mean values ± S.E., <italic>n</italic> = 3. Data were fit with a one-site binding model and the K<sub>d</sub> derived from curve fitting.</p></caption><graphic xlink:href="EMS207146-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>PAK4 phosphorylates MAST1 on S90.</title><p>A. Multiple sequence alignment of MAST1 residues surrounding S90 from <italic>Nematoda</italic> to <italic>Mammalia</italic>. S90 residue highlighted above, sequence used for ScoreSite prediction outlined in black box.</p><p>B. ScoreSite <sup><xref ref-type="bibr" rid="R29">29</xref></sup> prediction results using input sequence GRRWs*LASLP (s* represents S90 phosphosite). Top five hits shown in table, PAK4 highlighted in turquoise.</p><p>C. Radiometric kinase assay by PAK4 WT or PAK4 kinase dead (D442N) on MAST1<sup>D</sup>. Data are presented as mean values ± S.E., <italic>n</italic> = 3. Representative phosphorimage shown in inset.</p><p>D. Intact MS analysis of MAST1<sup>D</sup> before (black) and after (red) phosphorylation by PAK4 WT shown in panel C. Intensity of both samples were normalized to a scale of 0 to 1. Addition of phosphate (1P, 2P etc.) detected by each 80 Da shift.</p><p>E. Tandem MS analysis of MAST1<sup>D</sup> after phosphorylation by PAK4 WT shown in panel C. Phosphorylated serines are indicated in red. Top three sites (by spectral count) shown in table, S90 highlighted in light blue. See Supplemental File 3 for full data.</p></caption><graphic xlink:href="EMS207146-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>MAST1 S161 is an autoregulatory motif.</title><p>A. Multiple sequence alignment of MAST1 residues surrounding S161 from <italic>Nematoda</italic> to <italic>Mammalia</italic>. S161 residue highlighted above, AGC kinase recognition region outlined in black box.</p><p>B. Alignment of canonical AGC kinase substrate motif with MAST1<sup>156-162</sup>, where S161 is the phosphorylatable residue (red) and R156 (-5), R158 (-3), and L162 (+1) are in positions specifically involved in substrate recognition (black).</p><p>C. Consensus sequence of MAST1<sup>156-162</sup> from sequence alignment in panel A.</p><p>D. AlphaFold2 <sup><xref ref-type="bibr" rid="R24">24</xref></sup> model of MAST1 DUF (gold) and kinase domain (green), with region spanning S161 (dark blue) positioned in the catalytic site of MAST1. AMP-PNP molecule (pink) was incorporated into the model by superposition of MAST1 kinase domain with X-ray structure of Akt (PDB ID 1O6K) <sup>77</sup>.</p><p>E. Radiometric autophosphorylation assay with various concentrations of MAST1<sup>DK</sup> ΔS90 WT or kinase dead (D499N). Data are presented as mean values ± S.E., <italic>n</italic> = 3.</p><p>F. Intact MS analysis of MAST1<sup>DK</sup> ΔS90 WT (red) and kinase dead (D499N) (black) after autophosphorylation shown in panel E. Intensity of both samples were normalized to a scale of 0 to 1. Addition of phosphate in WT sample (1P, 2P etc.) detected by each 80 Da shift.</p><p>G. Tandem MS analysis of MAST1<sup>DK</sup> ΔS90 WT after autophosphorylation shown in panel E. Phosphorylated serines are indicated in red and residues involved in AGC kinase binding (-5, -3, +1) are in black. Top six serine sites (by spectral count) shown in table, S161 highlighted in dark blue. See Supplemental File 3 for full data.</p><p>H. Binding curves for MAST1<sup>DK</sup> ΔS90 ΔS161 and MAST1 peptides spanning S161, measured by fluorescence anisotropy. Data are presented as mean values ± S.E., <italic>n</italic> = 3. Data were fit with a one-site binding model and the K<sup>d</sup> derived from curve fitting.</p></caption><graphic xlink:href="EMS207146-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>MAST1 p-S90 or p-S161 forms a complex with 14-3-3η <italic>in vitro</italic>.</title><p>A. Analytical size exclusion chromatography (SEC) elution profiles of purified MAST1<sup>DK</sup> (yellow), purified 14-3-3η (red), and a co-purified complex of MAST1<sup>DK</sup> and 14-3-3η (dark blue).</p><p>B. Coomassie-stained SDS-PAGE gel of SEC fractions spanning elution peaks in panel A. Theoretical masses of each protein/complex shown in parentheses.</p><p>C. Tandem MS analysis of co-purified MAST1<sup>DK</sup> and 14-3-3η complex to determine phosphorylation state of MAST1 in the complex. Phosphorylated serines are indicated in red. S90, S161 (highlighted in dark blue), and S163 sites shown in table. See Supplemental File 3 for full data.</p><p>D. Gaussian fits from mass photometry of purified MAST1<sup>DK</sup> (yellow), purified 14-3-3η (red), and a co-purified complex of MAST1<sup>DK</sup> and 14-3-3η (dark blue). Experimentally measured masses of each protein/complex indicated above the Gaussian fit.</p><p>E. Analytical SEC elution profiles of purified MAST1<sup>D</sup> p-S90 (yellow), purified 14-3-3η (red), and an <italic>in vitro</italic>-formed complex of MAST1<sup>D</sup> p-S90 and 14-3-3η (light blue).</p><p>F. Coomassie-stained SDS-PAGE gel of SEC fractions spanning elution peaks in panel E. Theoretical masses of each protein/complex shown in parentheses.</p><p>G. Gaussian fits from mass photometry of purified MAST1<sup>D</sup> p-S90 (yellow), purified 14-3-3η (red), and an <italic>in vitro</italic>-formed complex of MAST1<sup>D</sup> p-S90 and 14-3-3η (light blue). Experimentally measured masses of each protein/complex indicated above the Gaussian fit.</p></caption><graphic xlink:href="EMS207146-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>MAST1 G519S mice exhibit an enlarged corpus callosum.</title><p>A. Schematic of MCC-CH-CM patient-derived mutations in MAST1 protein. G519S (mouse numbering) corresponds to G517S in humans. Mouse models have been generated for the highlighted L278del and G519S variants.</p><p>B. G519S animals were generated by injection of a single strand DNA repair template and Cas9/guide RNA into the pronucleus of mouse zygotes. Founder animals were identified by Sanger sequencing and backcrossed to C57Bl/6J animals for 10 generations.</p><p>C. Sequencing traces of MAST1 allele for control (+/+), heterozygous (G519S/+), and homozygous animals (G519S/G519S).</p><p>D. Nissl stain of coronal 8-week-old control (+/+) and heterozygous brains (G519S/+) shows an enlargement of the corpus callosum in mutants. Bregma = 0.86 mm.</p><p>E. Quantification of corpus callosal thickness in control (+/+) and heterozygous brains (G519S/+) (<italic>n</italic> = 5, P &lt; 0.05, paired, two-sided t-test with Bonferroni correction). Data are presented as mean values ± S.E.</p><p>F. Quantification of cortical thickness in control (+/+) and heterozygous brains (G519S/+) (<italic>n</italic> = 5, P &lt; 0.05, paired, two-sided t-test with Bonferroni correction). Data are presented as mean values ± S.E.</p><p>G. Western blot analysis on P0 cortical lysates for MAST1, MAST2, and MAST3 in control (+/+), heterozygous (G519S/+) and homozygous (G519S/G519S) animals.</p><p>H. Quantification of western blot in panel F (<italic>n</italic> = 3, * p &lt; 0.05; ** p &lt; 0.01; ***, p &lt; 0.001; **** p &lt; 0.0001, two-way ANOVA with Dunnet’s multiple comparisons test). Intensity of bands for MAST family members was normalized to corresponding GAPDH band. Data are presented as mean values ± S.E.</p></caption><graphic xlink:href="EMS207146-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Tau is a MAST1 substrate.</title><p>A. Schematic of MAST1 WT vs L278del vs G519S phosphoproteomics experiment. Number of significantly differentially phosphorylated peptides obtained in each comparison, and shared in both comparisons, shown in Venn diagram (<italic>n</italic> = 5 WT and homozygous litter-matched P0 mice, LIMMA test with 5% FDR threshold described in Hein <italic>et al</italic> <sup><xref ref-type="bibr" rid="R30">30</xref></sup> was applied).</p><p>B. Table displaying data from four of the 70 shared phosphosite hits in panel A. The four phosphosites listed all conform to the canonical AGC kinase substrate motif (phosphorylated serines indicated in red). MAPT (Tau) is highlighted in purple.</p><p>C. Sequence alignment of Tau<sup>209-215</sup> and MAST1<sup>156-162</sup>, where Tau S214 (substrate) and MAST1 S161 (autophosphorylation site) are aligned.</p><p>D. Volcano plot of phosphoproteomics analysis showing hyperphosphorylated sites (right) and hypophosphorylated sites (left) for L278del when compared to WT. Tau S214 highlighted in purple.</p><p>E. Volcano plot of phosphoproteomics analysis showing hyperphosphorylated sites (right) and hypophosphorylated sites (left) for G519S when compared to WT. Tau S214 highlighted in purple.</p><p>F. Radiometric kinase assay by MAST1<sup>DK</sup> ΔS90 WT or kinase dead (D499N) on Tau. Data are presented as mean values ± S.E., <italic>n</italic> = 10 for WT, 3 for D499N. Representative phosphorimage shown in inset.</p><p>G. Radiometric kinase assay by MRCKα on MLC2, overlaid on assay shown in E.</p><p>H. Tandem MS analysis of Tau after phosphorylation by MAST1<sup>DK</sup> ΔS90 WT shown in panel E. Phosphorylated serines are indicated in red and residues involved in AGC kinase binding (-5, -3, +1) are in black. S214 site (highlighted in purple) as well as three known Tau phosphorylation sites in its repeat domains shown in table. See Supplemental File 3 for full data.</p><p>I. Binding curves for 14-3-3η or θ and Tau peptides spanning S214, measured by fluorescence anisotropy. Data are presented as mean values ± S.E., <italic>n</italic> = 3. Data were fit with a one-site binding model and the K<sup>d</sup> derived from curve fitting.</p></caption><graphic xlink:href="EMS207146-f006"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><title>MCC-CH-CM mutations perturb MAST1 folding and kinase activity.</title><p>A. Structure of MAST1 4HB determined by NMR (PDB ID 2M9X). Patient mutations residing in 4HB highlighted in red and labelled.</p><p>B. Coomassie-stained SDS-PAGE gel of MAST1<sup>D</sup> ΔS90 WT, E194del, K276del, or L278del, expressed in <italic>E. coli</italic>. WCL = whole cell lysate, P = pellet, S = supernatant.</p><p>C. SEC elution profile of purified MAST1<sup>DK</sup> ΔS90 WT and K276del from Sf9 insect cells, void volume = 9 mL.</p><p>D. SEC elution profile of purified MAST1<sup>DK</sup> ΔS90 WT and G519S from Sf9 insect cells.</p><p>E. Radiometric kinase assay by MAST1<sup>DK</sup> ΔS90 WT, kinase dead (D499N), or G519S on Tau. Data are presented as mean values ± S.E., <italic>n</italic> = 3.</p></caption><graphic xlink:href="EMS207146-f007"/></fig><fig id="F8" position="float"><label>Figure 8</label><caption><title>Model of MAST1 regulation.</title><p>A group II PAK (PAK4-6) is activated by Cdc42 and phosphorylates MAST1 on S90. MAST1 p-S90 recruits 14-3-3η, forming an inactive trimeric complex, with S161 blocking MAST1’s substrate binding site. Upon binding of an unknown cofactor, the kinase domain of MAST1 adopts the active conformation and autophosphorylates S161, expelling it from the substrate binding site. p-S161 is sequestered by 14-3-3η, preventing dephosphorylation and reassembly with the kinase domain. Active MAST1 phosphorylates Tau on S214, resulting in its dissociation from microtubules, sequestration by 14-3-3η, and subsequent microtubule depolymerization.</p></caption><graphic xlink:href="EMS207146-f008"/></fig></floats-group></article>